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Abstract 
Disruptions to neuronal populations of corticosteroid receptors 
(glucocorticoid receptors; GR and mineralocorticoid receptors; MR) have been 
implicated in a range of stress-related pathologies; referred to as the Receptor 
Balance Hypothesis.  Traditionally, however, the receptor balance hypothesis only 
focuses on genomic populations of corticosteroid receptors, and does not account for 
membrane-associated corticosteroid receptors.  In this thesis, we tested the feasibility 
of using novel methods of reconstructing subcellular structures in order to 
characterise the distribution densities of GR and MR within the nucleus, and at 
excitatory post-synaptic terminals in the rat amygdala.  We used triple-label 
immunofluorescence in conjunction with confocal imaging to characterise the 
labelling of corticosteroid receptors.  Using Imaris™ software, we found that we 
could three-dimensionally reconstruct corticosteroid receptors, and perform object-
based colocalisation analysis, in order to quantify the populations of corticosteroid 
receptors located at excitatory post-synaptic sites.  This provides a novel method of 
quantifying corticosteroid receptors in amygdala tissue.  The adaptability of the 
method suggests that it could be applicable to a range of applications in stress 
research. 
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Chapter 1:  Introduction 
Acute stress helps the body respond to threats, potentially interacting with 
memory systems to support long-term memory of dangerous events and places 
(Sapolsky, Romero, & Munck, 2000).  In contrast to the beneficial effects of acute 
stress, stress can also alter pathologies such as addiction, anxiety disorders, and 
mood disorders (Daskalakis, Lehrner, & Yehuda, 2013; Millan et al., 2012).  
Moreover, long-term stress has negative impacts on human health (Millan et al., 
2012).  In the brain, these negative impacts can include the re-shaping of neurons and 
their synaptic connections.  These important and varied actions of stress are mediated 
by corticosteroids (cortisol in humans; corticosterone in rodents) a hormone released 
from the adrenal glands in response to stress. 
In the brain, corticosteroids act on both glucocorticoid receptors (GR) and 
mineralocorticoid receptors (MR).  Collectively known as corticosteroid receptors, 
disruptions to these receptors have been implicated in a range of disorders (Millan et 
al., 2012; Wingenfeld & Wolf, 2015).  GR and MR are both transcription factors – 
they interact with the genome to influence protein synthesis (Polman, de Kloet, & 
Datson, 2013).  In addition, both GR and MR have been identified at the membrane, 
where they are reported to have rapid membrane and sub membrane-signalling 
effects (Groeneweg, Karst, de Kloet, & Joels, 2011).  Nonetheless, the subcellular 
organization and distribution of membrane-associated MR and GR among brain 
subnuclei is still being characterised. 
The aim of this thesis was to provide new data about the distribution of 
membrane-associated MR and GR in the amygdala, including their relationship to 
synapses.  In order to understand the current research around these corticosteroid 
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receptors, it is important to firstly understand the role of cortisol– the main ligand for 
these receptors.  Thus, in this chapter I provide an introduction to the functional role 
of corticosteroids in the brain, and how corticosteroids in the amygdala have been 
proposed to modulate the brain’s emotional response to stress (Schwabe, Joels, 
Roozendaal, Wolf, & Oitzl, 2012).   
Functional Role of Corticosteroids 
To understand the importance of corticosteroid receptors, it is important to 
understand the functional role of the corticosteroids in the brain and the body.  In this 
thesis, the term corticosteroids is used to refer specifically to cortisol in humans or 
corticosterone in rodents; which are the body’s naturally occurring glucocorticoids 
(Groeneweg, 2014).  Corticosteroids have an active role within the body, both, under 
basal conditions (Horrocks et al., 1990) and under stress.  Corticosteroids can 
differentially affect cognition and behaviour, and these effects are dependent upon 
the distribution of corticosteroid receptors in the brain (Santos, Cespedes, & Viana, 
2014; Wingenfeld & Wolf, 2015).  In the brain, corticosteroids have been found to 
bind to two types of corticosteroid receptors: glucocorticoid receptors (GR, a Type II 
adrenocorticosteroid receptor); and mineralocorticoid receptors (MR; a Type I 
adrenocorticosteroid receptor) (Herman & Spencer, 1998; Reul & de Kloet, 1985; 
Teng, Zhang, Zhao, & Zhang, 2013).  I review these receptors in more detail in 
Chapter 2. 
Corticosteroids play a major role in the stress response.  When the stress 
response is triggered, usually during a threatening event (Iwasaki-Sekino, Mano-
Otagiri, Ohata, Yamauchi, & Shibasaki, 2008), the hypothalamic-pituitary-adrenal 
(HPA) axis is stimulated.  Corticotropin releasing hormone (CRH) is secreted from 
the hypothalamus (Herman et al., 2003), which activates the pituitary gland, resulting 
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in the release of adrenocorticotropic hormone (ACTH) into the blood stream 
(Zalachoras, 2014).  ACTH subsequently stimulates the adrenal glands, causing the 
release of corticosteroids (Bouchez et al., 2012).  Corticosteroids travel in the blood 
stream, and the lipophilic nature of corticosteroids allows them to cross the blood-
brain barrier, resulting in elevated levels of corticosteroids in the brain (Dedovic, 
Duchesne, Andrews, Engert, & Pruessner, 2009).  Once in the brain, they can have 
both acute and long-term effects on cognition and behaviour (Joels & Baram, 2009).  
Finally, corticosteroids act on receptors in the HPA-axis via negative feedback, 
subsequently inhibiting further release of corticosteroids (Groeneweg, Karst, de 
Kloet, & Joels, 2012), which is illustrated in Figure 1. 
Corticosteroids are also secreted during homeostasis (de Kloet, 2014).  At 
basal conditions, corticosteroid levels oscillate in time with the body’s circadian 
rhythms (Lightman et al., 2008).  The HPA-axis (Figure 1) secretes corticosteroids in 
pulses, resulting in peaks and troughs of corticosteroid levels (Lightman et al., 2008).  
In rodents, corticosterone trough concentration in the morning and peaks in the 
evening (Chaudhury & Colwell, 2002; Reul & de Kloet, 1985).  In humans, cortisol 
levels peak in the morning, and taper off during the day (Horrocks et al., 1990).  
Cortisol pulses are significantly reduced between 6pm to midnight (Horrocks et al., 
1990), with the trough occurring around midnight (Buckley & Schatzberg, 2005).   
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Figure 1.  The release of corticosteroids (Cort) via the Hypothalamic Pituitary 
Adrenal (HPA) Axis 
Circadian oscillations of corticosteroids are important for normal functioning 
(de Jong et al., 2000).  For example, corticosterone peaks have been demonstrated to 
promote dendritic spine formation after learning, and corticosterone troughs are 
important for stabilising learning-related dendritic spines (Liston et al., 2013).  These 
circadian pulses may also be important in maintaining the body’s responsiveness to 
stress (de Jong et al., 2000), mediating the duration of the stress response and 
facilitating stress recovery (Jacobson, Akana, Cascio, Shinsako, & Dallman, 1988).  
Stress increased corticosteroid levels can disrupt these natural corticosteroid 
oscillations, affecting HPA axis responsiveness (Millan et al., 2012).  This can have 
negative effects such as sleep disorders (Buckley & Schatzberg, 2005), depression 
(Keller et al., 2006; Solberg, Olson, Turek, & Redei, 2001), PTSD (Chaudhury & 
Colwell, 2002), epilepsy (Kumar et al., 2007), drug addiction (Simms, Haass-
Koffler, Bito-Onon, Li, & Bartlett, 2012) and pain (A. C. Johnson & Meerveld, 
2015). 
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The Amygdala and Corticosteroids 
Stress is an emotionally arousing experience, affecting cognition and 
behaviour (Schwabe et al., 2012).  In the brain, the amygdala is central to the stress 
response (Roozendaal, 2003).  Not only does the amygdala directly affect stress-
related learning and behaviour (Roozendaal & McGaugh, 1996; Roozendaal, 
Portillo-Marquez, & McGaugh, 1996; Roozendaal, Quirarte, & McGaugh, 2002), it 
also modulates memory processing in various brain regions (Harris, Holmes, de 
Kloet, Chapman, & Seckl, 2013; L. R. Johnson, McGuire, Lazarus, & Palmer, 2012; 
Kolber et al., 2008; Quaedflieg et al., 2015), such as the hippocampus (McReynolds 
et al., 2010), and medial prefrontal cortex (mPFC) (Schwabe et al., 2012).  On a 
cellular level, corticosteroid action in the amygdala affects gene transcription and 
neuronal excitability (Groeneweg et al., 2012).  On a systems level, corticosteroids in 
the amygdala affect its neuronal connectivity with other brain regions, differentially 
influencing learning and memory (Roozendaal, 2003; Schwabe et al., 2012). 
The structural organisation of the amygdala appears to affect the functional 
outcomes, where different subregions have different roles in the processing and 
behavioural outcomes of stressful situations (Sah, Faber, Lopez de Armentia, & 
Power, 2003).  The amygdala can be broadly divided into three subregions; the 
basolateral amygdala complex (BLA), the central amygdala (CeA) and the 
intercalated cells (ITC) (Giustino & Maren, 2015; Pape & Pare, 2010).  Moreover, 
the BLA nuclei can be further divided into two regions: the lateral amygdala (LA) 
and the basal nuclei (BA; referring to both the basolateral nuclei and the accessory 
basal nucleus);  which differ in structure and function (Giustino & Maren, 2015; 
Pape & Pare, 2010).  During stress, the LA, BA and CeA subregions receive a range 
of sensory information from various pathways including: olfactory projections, 
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somatosensory inputs, gustatory and visual areas, and auditory and visual projections 
(Sah et al., 2003).  As these three subregions have been shown to be differentially 
influenced by corticosteroids (Roozendaal, 2003; Roozendaal & McGaugh, 1996), 
they were the primary subnuclei targeted in this thesis.  The organisation of the LA, 
BA and CeA nuclei in the rain brain can be seen in Figure 2. 
 
Figure 2.  Depiction of the organisation of subnuclei (labelled for GR) in a coronal 
section of the rat amygdala, under wide-field epifluorescence.  Overlay adapted 
from Figure 31 of Stereotaxic Coordinates (Paxinos & Watson, 1997).  4-point axis 
refers to the orientation of the section: D, dorsal; V, ventral; M, medial; L, lateral.  
LA, lateral amygdala; BA, basal amygdala; CeA, central amygdala. 
The amygdala subnuclei have different functional roles in stress-related 
emotion and behaviour.  The LA is considered the input nuclei, and the CeA and BA 
as output nuclei for fight and flight associated responses (Amorapanth, LeDoux, & 
Nader, 2000).  The LA is proposed to be the region where the acquisition, but not the 
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expression, of fear learning.  LA lesion studies have demonstrated that lesions to the 
LA inhibits acquisition of fear memories (Amorapanth et al., 2000).  Single unit 
recording studies have further differentiated the LA as the primary input site, where 
neuronal excitability was shown to increase during threat acquisition (Bauer, Schafe, 
& LeDoux, 2002; Rosenkranz & Grace, 2002) but prior to any behavioural response 
(Repa et al., 2001).  Alternatively, the CeA has been demonstrated to be responsible 
for behavioural responses in stressful situations.  As the primary output of stress 
expression (Penzo et al., 2015), the CeA has been shown to project to numerous 
extra-amygdaloid brain regions (Cassell, Freedman, & Shi, 1999; Jolkkonen & 
Pitkänen, 1998), resulting in behavioural and physical changes, such as: increased 
heart rate, freezing or increased corticosteroid release (Parsons & Ressler, 2013).  
Lesion studies support this, showing suppression of the CeA only affected threat 
expression, but not threat learning (Amorapanth et al., 2000; Roozendaal & 
McGaugh, 1996).  Corticosteroids in the CeA, but not the BLA, influence drug-
seeking behaviours (Simms et al., 2012), and the knockdown of corticosteroid 
receptors in the CeA increased the expression of pain (A. C. Johnson & Meerveld, 
2015).  Finally, the BA is suggested to act as the interface between the LA and the 
CeA.  Selective inactivation of the LA or the CeA prior to fear conditioning has been 
demonstrated to inhibit fear expression, however, prior lesions of the BA had no 
effect on fear acquisition (Anglada-Figueroa & Quirk, 2005).  Alternatively, lesions 
to BA nuclei after learning blocked fear expression (Amano, Duvarci, Popa, & Pare, 
2011; Anglada-Figueroa & Quirk, 2005) suggesting that fear expression cannot occur 
without the BA acting as an intermediary between the LA and the CeA (Anglada-
Figueroa & Quirk, 2005).  In summary, during fight and flight associated responses: 
the LA is the ‘input centre’ where acquisition occurs, the CeA is the ‘output centre’ 
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responsible for fight and flight behaviour, and the BA acts as the interface between 
the two nuclei (Anglada-Figueroa & Quirk, 2005; Giustino & Maren, 2015; Pape & 
Pare, 2010). 
These functional differences in the subnuclei of the amygdala are affected by 
differences in morphology and connectivity (Sah et al., 2003).  The BA, LA and the 
CeA receive excitatory inputs from various brain regions (Sah & Lopez de Armentia, 
2003; Stefanacci & Amaral, 2002), which are activated during stress and fear 
(Parsons & Ressler, 2013).  The BLA-complex receives excitatory inputs from 
various brain regions including the hippocampus (Jin & Maren, 2015), thalamus 
(Bauer et al., 2002; Y. Zhou, Won, Karlsson, Zhou, & Rogerson, 2009) and mPFC 
(Vidal-Gonzalez, Vidal-Gonzalez, Rauch, & Quirk, 2006).  The CeA also receives 
inputs from other brain regions (Stefanacci & Amaral, 2002); however a lot of the 
glutamatergic inputs into the CeA appear to be intra-amygdaloid connections (Sah et 
al., 2003) from the LA (Sah & Lopez de Armentia, 2003) and the BA (Paré, Smith, 
& Paré, 1995; Vidal-Gonzalez et al., 2006).  Alternatively, the LA receives both 
excitatory and inhibitory inputs from the BA (Savander, Miettinen, LeDoux, & 
Pitkänen, 1997), and very limited input from the CeA (Jolkkonen & Pitkänen, 1998).  
During fear and stress, these excitatory pathways become disinhibited (Z. Liu et al., 
2014; Pape & Pare, 2010) resulting in increased neuronal activity in the LA, BA 
(Bauer et al., 2002; Vidal-Gonzalez et al., 2006; Y. Zhou et al., 2009), and CeA 
(Maras, 2014).  These excitatory inputs are summarised in Figure 3. 
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Figure 3.  The amygdala receives excitatory inputs from the hippocampus, thalamus 
and mPFC during stress – these circuits underlie Pavlovian conditioning and drive 
activation of the HPA axis from the CeA.  Excitatory intra-amygdaloid circuits are 
also activated during stress by corticosteroids. 
Corticosteroids interact with the amygdala and its connections, affecting 
learning and behaviour in both rodents and humans.  In rodents, stress has been 
shown to increase corticosterone levels in the amygdala and has been associated with 
changes in cognition and behaviour (Bouchez et al., 2012; Iwasaki-Sekino et al., 
2008; Kolber et al., 2008).  The effect of corticosteroids on the amygdala are further 
supported in studies that administer corticosteroids to rodents, demonstrating that 
corticosteroids in the LA (Monsey et al., 2014) the BA (Yang, Chao, Ro, Wo, & Lu, 
2007) and the CeA (A. C. Johnson & Meerveld, 2015; Shepard, Barron, & Myers, 
2000; Simms et al., 2012) can directly affect learning and behaviour.  The effects of 
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corticosteroids in the amygdala are also evident in human studies.  One fMRI study 
revealed the functional connectivity of the amygdala-mPFC pathway was mediated 
by cortisol.  During acute stress, participants were separated into two groups based 
on their salivary cortisol levels.  The researchers found that the group with an 
increased cortisol response had significantly stronger functional connectivity in the 
amygdala-mPFC pathway and the amygdala-hippocampus pathway (Quaedflieg et 
al., 2015).  This effect was further corroborated by Henckens, van Wingen, Joels, and 
Fernandez (2012), who directly administered hydrocortisone (a corticosteroid 
agonist) to participants, before conducting an emotional Stroop test.  They found that 
participants administered hydrocortisone had significantly less correct responses on 
the emotional Stroop task compared to the placebo group.  Moreover, fMRI scans 
displayed reduced amygdala inhibition in response to aversive words, and an 
increased coupling between the amygdala-mPFC pathway and amygdala-insula 
pathway (Henckens et al., 2012).  In summary, corticosteroids appear to interact with 
the amygdala and its pathways in both rodents and humans, affecting cognition and 
behaviour. 
Corticosteroid Receptors 
The effects of corticosteroids are limited to the cellular expression of GR and 
MR (Joels & Baram, 2009; Joels, Pasricha, & Karst, 2013).  The downstream effects 
of these receptors are dependent upon a variety of factors (Figure 4), such as the 
individual’s genetic history, the context and presentation of stress, the dosage of 
corticosteroids, the time domain of corticosteroids, and the brain region where the 
receptors are located (Groeneweg et al., 2011; Joels & Baram, 2009).  While the 
interaction between these factors is quite complex, the general view is that MR is 
involved in stress appraisal (Hamstra, de Kloet, van Hemert, de Rijk, & Van der 
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Does, 2015) and GR is involved in the body’s return to homeostasis (de Kloet, 2014).  
In accordance with these effects, de Kloet (1991) developed the Receptor Balance 
Hypothesis (explored in more detail in Chapter 2), which postulates that a balance 
between GR and MR populations regulate neuronal excitability (de Kloet, 2014) and 
is necessary for maintaining homeostasis and adaptive functioning (de Kloet, 2013).  
Imbalances in receptor density between GR and MR can have profound effects on 
learning and memory (Harris et al., 2013) and is a potential factor in the development 
of stress-related mental illnesses (de Kloet, 2014; Han, Ding, & Shi, 2014).  In 
Chapter 2, I review the literature surrounding corticosteroid receptors in more detail; 
however, due to the scope of this thesis, I focus primarily on the dosage and temporal 
factors of GR and MR located in the amygdala. 
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Figure 4.  Factors that interact with MR and GR to affect Cognition and Behaviour 
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A Rationale for Quantifying Corticosteroid Receptor Subpopulations 
GR and MR in the brain are important for maintaining homeostasis (Dedovic 
et al., 2009), and disruptions to the populations of GR and MR have been implicated 
in a range of disorders (described earlier)..  The receptor balance hypothesis suggests 
that these disorders are influenced by an imbalance between the populations of GR 
and MR (de Kloet, 2014).  Traditionally the receptor balance hypothesis of GR and 
MR refers to an imbalance between genomic populations of GR and MR (de Kloet, 
2013), and the role of membrane-associated populations is unclear.  Membrane-
associated corticosteroid receptors (described in more detail in Chapter 2) have been 
located at synapses in the LA (L. R. Johnson, Farb, Morrison, McEwen, & LeDoux, 
2005; Prager, Brielmaier, Bergstrom, McGuire, & Johnson, 2010) and functional 
effects of fast-acting, effects have been demonstrated within the BA (Sarabdjitsingh 
& Joels, 2014; Sarabdjitsingh, Kofink, Karst, De Kloet, & Joels, 2012).  However, 
the relative distributions of these membrane-associated receptors in relation to 
genomic receptors, are yet to be explored – especially in the different subnuclei of 
the amygdala.  Understanding the relative importance of these receptors could add a 
new dimension to understanding the balance hypothesis; especially within the 
amygdala, which has not been demonstrated to be sensitive to the balance hypothesis 
(Caudal, Jay, & Godsil, 2014; Han et al., 2014). 
The literature to date has not directly compared the populations of both 
genomic and synaptic receptors of GR and MR within the brain.  We aimed to 
address this by comparing the genomic and synaptic populations of GR and MR 
within the amygdala.  In this thesis, we validated a protocol for immunofluorescence 
and piloted a novel approach of visualising and quantifying corticosteroid receptors 
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at synapses.  Using this approach, we were able to provide some preliminary data 
about these distributions for use in future experiments. 
Another gap in the literature is the proportion of corticosteroid receptors 
located at synapses.  Previous electron microscopy studies have identified both GR 
and MR within some excitatory synapses in the LA.  However, there was limited 
data on the number of excitatory synapses that actually contained GR and MR 
(Johnson 2005; Prager et al, 2010).  In this thesis, we were interested in testing the 
feasibility of a new method, in order to provide some preliminary data that 
characterised the distribution of excitatory post-synaptic terminals containing GR or 
MR, in the amygdala.  Finally, due to the different effects of fast-acting 
corticosteroid receptors, between the LA, CeA and BA (Karst et al., 2010); we were 
interested in seeing if there were any subregional differences in the populations of 
GR and MR located at excitatory post-synaptic sites. 
Fluorescent Imaging and Reconstruction of Corticosteroid Receptor Subtypes 
The distribution densities of corticosteroid receptors have been characterised 
using a range of methods that included: autoradiography (Reul & de Kloet, 1985; 
Reul, van den Bosch, & De Kloet, 1987), cell fractionation (Aronsson et al., 1988; 
Caudal et al., 2014; Han et al., 2014) and microscopy (Ahima & Harlan, 1990; 
Moutsatsou, Psarra, Paraskevakou, Davaris, & Sekeris, 2001; van Steensel et al., 
1996).  However, most of these studies either focus on genomic corticosteroid 
receptors, or do not distinguish between different receptor subpopulations at all.  As 
such, the distribution of membrane-associated receptors in the brain is still unclear.  
In this section I will discuss the novel method we used to investigate the localisation 
of membrane-associated corticosteroid receptors at synapses.  The first part describes 
the use of multiple labelling immunofluorescence in colocalisation analysis, and the 
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second part describes the novel object-based analysis used in this study for 
colocalisation analysis. 
Multiple labelling immunofluorescence can be used to visualise the 
distribution of receptor proteins (Daly & McGrath, 2003), and to further characterise 
the colocalisation of subcellular organelles (Bolte & Cordelières, 
2006).Colocalisation studies in neuroscience tend to use antibodies coupled to 
fluorescent markers which label the desired structures (e.g. receptor protein) on a 
sample (Bolte & Cordelières, 2006; Zinchuk & Grossenbacher-Zinchuk, 2009).  
These markers can be subsequently imaged using a confocal microscope, and the 
association between two fluorescent markers would suggest an association between 
two subcellular structures (Dunn, Kamocka, & McDonald, 2011).  Previous studies 
have used confocal immunofluorescence to characterise corticosteroid receptors.  For 
example, van Steensel et al. (1996) used confocal immunofluorescence to determine 
the spatial distribution of GR and MR within neuronal nuclei in the hippocampus.  
van Steensel and colleagues (1996) were able to simulate the relative distributions of 
GR and MR in CA1 nuclei, and provide qualitative information about the clustering 
of GR and MR.  Immunofluorescence has also been used to measure membrane-
associated corticosteroid receptors.  Oppong et al. (2014) measured the movement of 
GR to the membrane by fluorescently labelling the plasma membrane of mast cells in 
red, and GR in green.  When the GR was colocalised with the membrane, yellow 
fluorescence was emitted. 
For colocalisation analysis, confocal imaging provides high resolution images 
(Bolte & Cordelières, 2006).  Confocal imaging eliminates out of focus light, making 
it appropriate for use with thick brain sections (Bolte & Cordelières, 2006).  The low 
temporal resolution, however, restricts imaging to fixed sections (Bolte & 
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Cordelières, 2006).  Compared to other imaging techniques such as electron 
microscopy or light microscopy, confocal imaging has an added z-resolution, making 
it easier to three-dimensionally reconstruct neuronal structures (Bacallao, Kiai, & 
Jesaitis, 1995).  Moreover, the added z-resolution allows for object-based 
colocalisation analysis and volumetric quantification (Fogarty, Hammond, Kanjhan, 
Bellingham, & Noakes, 2013).  Finally, the use of immunofluorescence in 
conjunction with confocal imaging also had the added advantage of providing 
descriptive information about the distribution densities of GR and MR; as opposed to 
cell fractionation and radiography methods (Daly & McGrath, 2003; Zinchuk & 
Grossenbacher-Zinchuk, 2009). 
Advances in technology (Zinchuk & Grossenbacher-Zinchuk, 2009) has led 
to an increase in the use of object-based methods in colocalisation analysis (Bolte & 
Cordelières, 2006; Lagache, Sauvonnet, Danglot, & Olivo-Marin, 2015).  Object-
based methods allow for spatial exploration of the colocalised signals along the z-
axis (Bolte & Cordelières, 2006), and is suited for puncta labelling(Fogarty et al., 
2013; Lagache et al., 2015), such as that of GR and MR (van Steensel et al., 1996).  
Fogarty et al. (2013) developed a semi-automated object-based method, which 
utilised the commercial software Imaris (Bitplane) to map the distribution of synaptic 
inputs.  By performing a three-dimensional reconstruction of fluorescently labelled 
structures, Fogarty et al. (2013) subsequently used object-based analysis for 
colocalisation.  Fogarty et al. (2013) have stated that their method, which I refer to in 
this thesis as Fogarty’s approach, can be used to visualising various subcellular 
structures.  In this thesis, we tested the feasibility of adapting this approach to 
quantify the 3D distribution of GR and MR; both within the nucleus and at 
excitatory-post synaptic terminals. 
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Object-based methods of colocalisation have multiple advantages compared 
with traditional methods of colocalisation (Lagache et al., 2015).  Object-based 
methods are less sensitive to noise and pixel-shift, and are more accurate and robust 
than traditional colocalisation methods (Lachmanovich et al., 2003; Lagache et al., 
2015).  Fogarty’s approach applied colocalisation parameters to images in batch 
(Fogarty et al., 2013); as such it provided a more objective and consistent method of 
quantifying synapses than traditional counting (Lachmanovich et al., 2003).  
Furthermore, the accuracy of colocalised synaptic sites calculated using their 
approach was further corroborated by electrophysiological recordings and electron 
microscopy data (Fogarty et al., 2013).  Another strength of this approach is the 
sensitivity of the software used.  Signals in the middle of a section are not always 
visible to the human eye, these objects could be missed during manual counting.  As 
the software is more sensitive to the signal, it is more accurate at quantifying objects 
(Fogarty et al., 2013).  Finally, the semi-automated nature of this approach allows for 
increased throughput. 
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Thesis Objectives and Outline 
Disruptions to the corticosteroid receptors have implications in a range of 
stress-related disorders (Millan et al., 2012).  Understanding the distribution of 
corticosteroid receptors in the amygdala could further unravel the stress system.  The 
overarching objective was to adapt Fogarty’s approach to visualise the distribution of 
GR and MR in the amygdala.  More specifically I aimed to: 
1. Validate the antibodies and reagents from the electron-microscope studies 
conducted by L. R. Johnson et al. (2005) and Prager et al. (2010), for use in 
multiple labelling immunofluorescence. 
2. Investigate the distribution of GR and MR in nuclei and at excitatory post-
synaptic terminals. 
3. Quantify the balance between these receptors in stress-naïve animals in order 
to provide a foundation for future studies into stress. 
To investigate these aims, I begin by reviewing the literature surrounding 
corticosteroid receptors in Chapter 2.  More specifically, I review the dual system of 
GR and MR, and subsequently describe their distribution within the subnuclei of the 
amygdala.  I further describe the temporal effects of corticosteroid receptors, and 
review the literature surrounding the two subpopulations of GR and MR within the 
different amygdala subnuclei.  Finally, I review the role of GR and MR in the 
Receptor Balance Hypothesis, and how the subpopulations of GR and MR could add 
a new dimension to understanding the ratio of GR:MR in the amygdala. 
In Chapter 3, I describe the general method used in this thesis.  In this chapter 
I provide an overview of the variables and the procedure; I also discuss the biometric 
properties of the antibodies chosen and their respective labels.  Chapter 3 also details 
the controls used, which were further tested in Chapter 4 (protocol validation).  
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Finally, in Chapter 3, I describe the ethical implications of animal research, and 
briefly discuss the applicability of using animals to investigate corticosteroid 
receptors. 
In Chapter 4 (protocol validation), we test the feasibility of using multiple-
label immunofluorescence as a method of visualising the distribution of GR and MR.  
In this chapter, we optimised the reagents used in this thesis, and standardised a 
protocol for future research.  We also tested the feasibility of using triple-label 
immunofluorescence for visualising the distributions of GR and MR. 
In chapter 5 (corticosteroid receptor densities in the amygdala), we tested the 
feasibility of adapting Fogarty’s approach, in order to three-dimensionally 
reconstruct GR and MR in the amygdala.  Using the protocol developed in Chapter 4, 
we used confocal microscopy to image amygdala tissue sections, and subsequently 
reconstructed these images in 3D in Imaris (Bitplane).  Following this, we used 
object-based methods to create colocalised objects for quantification and using the 
data from this technique, we performed some preliminary analyses to see if there 
were any differences in volumetric density. 
In Chapter 6, I discuss the findings from Chapter 5.  I discuss the strengths 
and weakness of using Fogarty’s approach, and provide suggestions for future 
research.  Moreover, I also discuss some potential implications of our findings in 
relation to stress.  Finally, all results are summarised in Chapter 7, and discussed in a 
broader context. 
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Chapter 2:  Corticosteroid Receptors 
The distribution of corticosteroid receptors are the limiting factor for the 
downstream signalling effects of corticosteroids (Joels & Baram, 2009), and 
disruptions to the populations of these receptors have been implicated in a range of 
stress-related pathologies (Millan et al., 2012).  In this chapter, I review the current 
literature surrounding the corticosteroid receptors, GR and MR, in the brain.  In the 
first section I provide a brief overview of the dual system of GR and MR.  In the 
second section, I subsequently review the previous research surrounding the 
distribution of GR and MR in the amygdala.  In the third section, I introduce the two 
subtypes of GR and MR; slow genomic receptors and fast membrane-associated 
receptors.  In this section I also review amygdala-specific effects of these receptor 
subpopulations.  In the fourth section of this literature review I discuss the Receptor 
Balance Hypothesis, where I aim to consolidate the temporal effects of corticosteroid 
receptors into the receptor balance hypothesis.  Additionally, I provide a rationale for 
the current research.  In the final section of this chapter, I summarise the literature 
and discusses the current gaps in our understanding of these receptors. 
Dosage Effects of Corticosteroids on Corticosteroid Receptors 
One manner in which MR and GR affect learning and memory, appears to be 
dependent on the dosage of corticosteroid levels in the brain (Prager & Johnson, 
2009; Sandi, 2011).  Corticosteroids have been demonstrated to have different 
binding affinities for MR and GR.  Corticosteroids have a higher binding affinity for 
MR, and at low levels of circulating corticosterone, more MR will be bound than GR 
(Conway-Campbell et al., 2007; Reul et al., 1987).  The opposite effect is seen in the 
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case of GR, which has a ten-times lower binding affinity than MR, and is only 
activated during higher levels of circulating corticosteroids in the brain (Conway-
Campbell et al., 2007; Reul et al., 1987).  Consequently, it has been suggested that 
MR are bound during basal levels, at homeostasis (Joels, Karst, DeRijk, & de Kloet, 
2008) and GR are occupied during the circadian peaks and higher levels of stress (de 
Kloet, Karst, & Joels, 2008; Joels et al., 2008).  However, the mechanisms of these 
receptors are not simply dosage dependent, they are also affected by their location, 
both within the neuron, and the region of the brain (Quaedflieg et al., 2015; 
Sarabdjitsingh & Joels, 2014; Q. Wang et al., 2014). 
Corticosteroid Receptors in the Amygdala 
Corticosteroid receptors are distributed throughout the body and the brain 
(Reul & de Kloet, 1985), however the density of GR and MR populations differ 
across locations.  GR has been found to be widely expressed in the central nervous 
system with a higher density in cortical regions such as the hippocampus and 
amygdala (Reul & de Kloet, 1985; Teng et al., 2013).  MR is less ubiquitous and 
found to be densest  in limbic areas, in particular the hippocampus and the amygdala, 
as well as the pre-frontal cortex (Ahima, Krozowski, & Harlan, 1991; Joels et al., 
2008).  Both populations of corticosteroid receptors have both been found to be 
expressed in the amygdala (Reul & de Kloet, 1985), and are believed to be involved 
in mediating the cognitive and behavioural effects that arise from stress and fear 
(Roozendaal, 2000).  It should be noted that corticosteroid receptors are not limited 
to neurons, but also located in glial cells (Matsusue, Horii-Hayashi, Kirita, & Nishi, 
2014).  Moreover, the role of GR and MR in glial cells in the amygdala may also be 
implicated in stress-related pathologies, such as depression (Q. Wang et al., 2014). 
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The distribution densities of GR and MR also vary between the subnuclei of 
the amygdala (introduced in Chapter 1).  Autoradiography studies have shown that in 
naïve animals, with higher levels of GR in the amygdala compared to MR (Marlier et 
al., 1997).  It has been found that the CeA has higher levels of GR compared to MR 
(Reul & de Kloet, 1985; Reul et al., 1987), however there is limited information 
about these receptor populations in the other subnuclei of the amygdala.  Studies 
measuring receptor mRNA, provided more detail about receptor densities and in 
naïve rodents, significantly higher levels of GR mRNA in the amygdala, compared to 
MR mRNA (Han et al., 2014; Patel et al., 2000).  The highest densities of GR mRNA 
were found within the CeA, followed by the LA and BA (Aronsson et al., 1988; 
Morimoto, Morita, Ozawa, Yokoyama, & Kawata, 1996).  For MR, a similar trend 
followed, with highest mRNA densities in the CeA and then the BA (Herman, 1993).  
It should be noted that mRNA quantification is a limited indicator of final receptor 
protein densities (Herman, 1993).  For proteins like GR and MR that are affected by 
post-transcriptional factors (Groeneweg, 2014; Ratman et al., 2013), mRNA 
expression may not be the most accurate indicator of receptor density (Helmstetter, 
Parsons, & Gafford, 2008; Rizzo et al., 2014). 
Studies examining GR and MR immunoreactivity tend to provide a higher 
resolution distribution of corticosteroid receptors compared to mRNA in situ 
hybridisation and autoradiography (Morimoto et al., 1996).  While some studies have 
shown that these methods have similar trends in receptor density, the density of 
immunolabelled receptors are not completely concordant with mRNA results 
(Marlier et al., 1997; Morimoto et al., 1996).  Between GR and MR populations, Han 
et al. (2014) found that GR mRNA levels in the amygdala were significantly higher 
than MR mRNA, and although GR immunoreactive neurons were higher than MR, 
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the difference was not significant.  Morimoto et al. (1996) compared GR populations 
in naïve rodents and found a similar trend between GR mRNA levels and GR 
immunoreactive neurons.  The highest densities of GR were in the CeA and 
moderate densities were found in the LA and BA (Morimoto et al., 1996).  Studies of 
MR density have found more variable results (Ahima et al., 1991).  Autoradiography 
studies found MR was largely restricted to limbic areas (Reul & de Kloet, 1985), 
however, mRNA and immunoreactivity studies found MR distributed throughout the 
brain (Ahima et al., 1991).  Within the amygdala subnuclei, MR immunoreactivity 
was had the highest density in the CeA, followed by the LA, with the lowest 
densities in the BA (Ahima et al., 1991).  Although this followed a similar trend to 
MR mRNA levels, mRNA numbers appeared to overestimate MR populations 
compared to immunoreactive studies (Herman, 1993).  Overall, MR and GR 
densities in the subregions of the amygdala are not characterised as well as the 
subregions of the hippocampus (Cohen, Kozlovsky, Matar, Zohar, & Kaplan, 2014; 
Reul et al., 1987; Sampedro-Piquero, Begega, & Arias, 2014; Zhe, Fang, & Yuxiu, 
2008).  Moreover, studies that employ immunolabelling, to provide higher cellular 
resolution of receptor density, are even more scarce (Ahima et al., 1991). 
Temporal Effects of Corticosteroid Receptors 
The location of GR and MR within a neuron can affect the temporal effects of 
these corticosteroid receptors.  Classically, GR and MR were found to exist within 
the cytoplasm as genomic GR (gGR) and genomic MR (gMR) (Reul & de Kloet, 
1985); operating in a “slow” manner (hours to days), affecting gene transcription 
(Datson, van der Perk, de Kloet, & Vreugdenhil, 2001; Groeneweg et al., 2014; van 
Steensel et al., 1996).  However, genomic receptors could not account for the “fast” 
effects (seconds to minutes) of corticosteroids; thus it was proposed that GR and MR 
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must operate through non-genomic mechanisms (de Kloet et al., 2008).  Fast-acting, 
non-genomic corticosteroid receptors were further differentiated from genomic 
receptors via their intracellular localisation, and were proposed to reside at the 
plasma-membrane of neurons as membrane-associated GR (mGR) and MR (mMR) 
(Joels et al., 2013).  Thus, GR and MR have two further subtypes: slow-acting, 
genomic receptors; and fast-acting, membrane-associated receptors (Groeneweg et 
al., 2012; Prager & Johnson, 2009); the differential distributions are depicted in 
Figure 5. 
 
Figure 5.  Distribution of Genomic and Synaptic GR and MR within a neuron.  
Genomic GR and MR are located within the cytoplasm, and translocate to the 
nucleus when bound.  Synaptic GR and MR are located near or within the 
membrane at synapses; when activated, these receptors can affect 
neurotransmission. 
When inactive, unbound genomic corticosteroid receptors typically reside 
within the cytoplasm of a neuron (Ahima & Harlan, 1990; Nishi, Ogawa, Ito, 
Matsuda, & Kawata, 2001).  When corticosteroids enter a neuron, they bind with 
gGR or gMR in the cytoplasm, forming cortisol-receptor complexes (Groeneweg et 
al., 2014; Nishi et al., 2001).  Now in their active state, these ligand-receptor 
complexes homodimerise as: GR-GR or MR-MR complexes (Herman & Spencer, 
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1998; van Steensel et al., 1996);or heterodimerise as: GR-MR complexes (W. Liu, 
Wang, Sauter, & Pearce, 1995).  These ligand-receptor complexes subsequently 
translocate to the nucleus (Groeneweg et al., 2014) where they bind to glucocorticoid 
binding sites (GBS).  Within the nucleus gGR or gMR can directly or indirectly 
interact with DNA to, respectively, activate or supress gene transcription (Nishi et 
al., 2001; Polman et al., 2013).  While these two receptors have some overlap in the 
DNA binding domain, they can differentially regulate these genes and affect function 
(Le Menuet & Lombès, 2014). 
These genomic receptors can have a range of biological and behavioural 
effects (Hamstra et al., 2015; Ratman et al., 2013).  gGR has been shown to affect 
Arc transcription in the hippocampus, affecting dendritic plasticity and long-term 
fear memories (Chen, Bambah-Mukku, Pollonini, & Alberini, 2012).  Chronic 
administration of corticosterone has been demonstrated to mediate the enhancement 
of anxious behaviour (Santos et al., 2014), and administration of GR antagonists 
have been shown to later supress fear conditioning (M. Zhou et al., 2010).  The slow 
effects of MR have been shown to be involved in acquisition of fear memories (M. 
Zhou et al., 2010).  However, it has also been shown that increased expression of 
gMR has been implicated in improved emotional resilience (Hamstra et al., 2015; 
Klok et al., 2011). 
The effects of genomic receptors are usually visible hours to days after the 
initial onset of a stressor (Groeneweg et al., 2011), and do not account for immediate 
(second to minutes) biological changes to stress (Popoli, Yan, McEwen, & Sanacora, 
2011; Sandi, 2011).  For example, rats that underwent a 15 minute forced-swim 
stress test showed increases in corticosterone levels in the BLA-complex (Bouchez et 
al., 2012), and administration of spironolactone (MR antagonist) rapidly reduced the 
 Chapter 2: Corticosteroid Receptors 27 
expression of conditioned fear (de Oliveira & Reimer, 2014).  In humans, Henckens 
et al. (2012) aimed to determine the temporal effects of cortisol on the amygdala in 
the presence of emotional stimuli.  In a randomised, placebo-controlled trial, 
experimental participants were administered hydrocortisone (a cortisol agonist) and 
given an emotional interference task.  The rapid effects (60 minutes) of 
hydrocortisone, increased participants’ sensitivity to emotional interference 
compared to the slower effects (270 minutes), which did not differ from the control 
group.  An fMRI was used to measure neuronal activity and found that for the rapid 
effects of corticosteroids, the amygdala was less inhibited towards emotional 
interference.  van Ast, Cornelisse, Meeter, Joels, and Kindt (2013) also found 
differences in the temporal effects of cortisol.  Administration of hydrocortisone 
found that the rapid effects (30 minutes) of cortisol impaired the contextualisation of 
emotional memory; alternatively, the slow effects (270 minutes) enhanced it.  
Similarly, Quaedflieg et al. (2015) found that, during acute stress, participants with 
increased cortisol levels had increased functional connectivity between the amygdala 
and the mPFC, and between the amygdala and the hippocampus.  Interestingly, these 
biological differences did not translate behaviourally as Quaedflieg et al. (2015) 
found that hydrocortisone did not appear to have an effect on perceived stress. 
These “fast” cognitive and behavioural effects were suggested to be initiated 
by corticosteroid receptors located at the membrane, as opposed to receptors within 
the nucleus (Joels et al., 2013).  These membrane-associated receptors were 
demonstrated to exist in the neuron through electrophysiological recordings (Karst et 
al., 2010; Karst et al., 2005; Sarabdjitsingh & Joels, 2014), synaptosome fractions 
(Moutsatsou et al., 2001; C. Wang & Wang, 2009), and electron microscopy (L. R. 
Johnson et al., 2005; Komatsuzaki et al., 2012; Prager et al., 2010).  Moreover these 
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membrane-associated receptors have been found at synapses (Prager & Johnson, 
2009), at both pre- and post-synaptic sites on dendrites and dendritic spines 
(Komatsuzaki et al., 2012).  These membrane-associated receptors are believed to be 
coupled with signalling proteins which can affect neurotransmission (Groeneweg et 
al., 2012; Popoli et al., 2011), possibly influencing glutamate release at pre-synaptic 
sites, and affecting glutamate receptor mobility at post-synaptic sites (Joels et al., 
2013; Sandi, 2011) (Figure 5).  In addition, membrane-associated receptors may even 
have effects further downstream, affecting protein synthesis (Roozendaal et al., 
2002). 
While the literature is still emerging, the membrane-associated effects of 
corticosteroid receptors have been better characterised in the hippocampus than in 
the amygdala (Groeneweg et al., 2012; Popoli et al., 2011; Prager & Johnson, 2009).  
The literature available, however, has suggested that corticosteroid receptors in the 
amygdala function in a very different manner to the hippocampus (Groeneweg et al., 
2011).  Within the hippocampus, MR and GR neuronal excitability follows an 
inverted-U trend.  Moderate doses of corticosteroids were shown to act on MR, 
inducing long-term potentiation (LTP) and increasing neuronal activity (Chatterjee & 
Sikdar, 2014; Karst et al., 2005).  Alternatively, high doses of corticosteroids acted 
on both MR and GR, subsequently depressing post-synaptic excitability in neurons 
(Chatterjee & Sikdar, 2014; Karst et al., 2005).  The amygdala has displayed an 
opposite trend.  In the BLA-complex, higher levels of corticosteroids increased 
excitability at the post-synaptic terminal (Karst et al., 2010; Sarabdjitsingh & Joels, 
2014).  Moreover, GR-MR-mediated excitability was slower in onset, and less 
transient than in the hippocampus (Karst et al., 2010; Sarabdjitsingh & Joels, 2014).  
It was suggested that mMR has a lower affinity towards corticosteroids than gMR, 
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and is only activated during stress at higher levels of corticosteroids (Karst et al., 
2005).  When activated, mMR mediates the initial increase of LTP, and this increase 
is maintained by gGR (Karst et al., 2010).  When corticosteroid levels were increased 
further, through a second pulse of corticosterone, mGRs were activated, which 
depressed neuronal excitability (Karst et al., 2010).  It should also be noted, that 
corticosteroid receptor-mediated excitability was also dependent on the history of 
stress.  Animals that were stressed prior to corticosterone administration had elevated 
corticosteroid levels similar to exogenous application of corticosterone.  Thus, 
further administration of corticosterone resulted in depressed neuronal activity (Karst 
et al., 2010; Sarabdjitsingh & Joels, 2014), suggesting that repeated exposure to 
stressors can depress neuronal excitability via interactions with GR and MR (Figure 
6). 
 
Figure 6.  Corticosteroid receptors in the BLA-complex mediate neuronal excitability 
differently to the hippocampus.  Corticosteroids increase neuronal excitation in the 
BLA-complex, through mMR.  This excitability is maintained through gGR.  Further 
application of corticosterone depressed neuronal excitability through mGR. 
Adapted from research by Karst et al. (2010), Groeneweg et al. (2011), and 
Sarabdjitsingh and Jӧels (2014). 
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Interestingly, out of the LA, BA and CeA, the highest densities of both GR 
and MR have been found in the CeA (Ahima & Harlan, 1990; Ahima et al., 1991).  
However, this does not appear to be reflected functionally, as corticosterone 
application to CeA neurons did not seem to affect excitation at post-synaptic 
terminals (Karst et al., 2010).  This may be due to higher density of inhibitory 
connections in the CeA, which mediate the excitability in CeA neurons (Cassell et 
al., 1999; Jolkkonen & Pitkänen, 1998).  This is further reflected in the morphology 
of neurons in rats exposed to single prolonged stress.  Cui, Sakamoto, Higashi, and 
Kawata (2008) found that, after stress, there was a significant increase in dendritic 
spines in the BLA but not in the CeA, suggesting the CeA may not be as susceptible 
to stress-related changes as the BLA.  Moreover, there was an increase in GR and 
MR labelling in excitatory neurons in the BLA, but no difference in the CeA between 
the stress and control groups (Cui et al., 2008).  The distribution of membrane 
associated corticosteroid receptors at CeA synapses is currently unclear.  Previous 
research on distributions of GR and MR have been limited to mRNA or genomic 
receptors; as such further investigation is warranted. 
Receptor Balance Hypothesis 
The Receptor Balance Hypothesis (introduced in Chapter 1) states that a 
balance between the dual receptor system of GR and MR is necessary for an adaptive 
stress response (de Kloet, 1991).  GR and MR are believed to operate in a 
complementary fashion where MR maintains homeostasis during basal levels of 
stress, and GR returns the body to homeostasis after stress (de Kloet, 2014).  
Furthermore, the receptor balance hypothesis posits that an imbalance between the 
populations of GR and MR results in a dysregulation of the HPA-axis and a 
vulnerability to mental illness (de Kloet, 2014; Dedovic et al., 2009). 
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Support for the receptor balance hypothesis has been found within the regions 
of the mPFC and hippocampus (Caudal et al., 2014; Zhe et al., 2008), where stress-
induced increases in corticosterone can result in decreases in MR or increases in GR 
(de Kloet, 2014), creating imbalances in between GR and MR.  It should be noted 
that the balance between GR and MR populations are not zero-sum.  That is, an 
increase in GR does not necessarily result in a decrease in MR, or vice versa (Harris 
et al., 2013).  Although the signalling pathways between GR and MR appear to 
interact, the expression of GR and MR populations appear to be quite independent of 
each other (Harris et al., 2013).  Thus the receptor balance hypothesis is not about the 
sole expression of GR or MR, rather it is the ratio of GR:MR expression (Cotella, 
Durando, & Suarez, 2014; de Kloet, 2014).  Within the hippocampus, the ratio of 
gGR:gMR binding can be altered by varying the concentration of corticosteroids 
(Polman et al., 2013).  As such, de Kloet (2014) suggested that imbalances between 
the genomic populations of corticosteroid receptors in the hippocampus are 
responsible for the maladaptive effects of stress.  Within the amygdala, however, 
evidence supporting the receptor balance hypothesis is mixed. 
Studies that support the receptor balance hypothesis in the amygdala suggest 
that over- or under-expression in GR and/or MR can negatively affect individuals.  In 
rodents, increased populations of MR, but not increased populations of GR, appear to 
be protective against stress.  Mitra, Ferguson, and Sapolsky (2009) found that, at 
basal levels of stress, over-expression of MR in the BLA-complex resulted in 
increased exploration behaviours in rats.  In stressed rats, an over-expression of MR 
in the BLA resulted in reduced plasma corticosterone levels and reduced anxious 
behaviours (Mitra et al., 2009).  Deletion of GR in the CeA in mice has resulted in 
significantly lower neuronal activity in the CeA at basal levels, and in both the CeA 
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and the BLA-complex during stress (Kolber et al., 2008).  Moreover, GR-knockout 
mice were observed to have reduced freezing, suggesting that lower levels of 
activated GRs may weaken fear memory consolidation, and in turn, anxious 
behaviours (Kolber et al., 2008).  In humans, Q. Wang et al. (2014) found that 
humans with depression had a higher density of GR in both neurons and astrocytes in 
the amygdala compared to bipolar patients and healthy controls.  These studies, 
however, did not compare the ratio of GR:MR directly.  Thus, while the population 
of these stress receptors may differ from healthy controls, it is arguable whether the 
ratio between GR:MR is significantly different. 
Studies which have directly compared ratios of GR:MR have found that the 
amygdala does not seem to be sensitive to the receptor balance hypothesis.  After 
single prolonged stress, Han et al. (2014), found that, while expressions of GR and 
MR were significantly reduced after stress, the GR:MR ratio did not change.  Caudal 
et al. (2014) found that stress increased gMR expression in the nucleus, albeit not 
significantly.  In accordance with previous literature, they also found that the 
GR:MR ratio of genomic receptors was significantly different after stress in the 
hippocampus and mPFC, but not within the amygdala (Caudal et al., 2014).  In 
support of this, other research has also demonstrated that GR expression in both the 
lateral amygdala and the central amygdala do not vary, even after administration of 
corticosterone, although this may be due to ceiling effects as control animals also had 
high levels of GR (Santos et al., 2014). 
These studies suggest, that while the amygdala may be sensitive to 
differences in GR expression or MR expression it is possible that the ratio of GR:MR 
does not change.  Alternatively, differentiating between genomic and membrane-
associated receptors may provide a new dimension to understanding the receptor 
 Chapter 2: Corticosteroid Receptors 33 
balance hypothesis in the amygdala.  As discussed earlier, genomic receptors interact 
with membrane-associated receptors with different functional effects in the amygdala 
compared to the hippocampus (Joels et al., 2013; Karst et al., 2010; Pasricha, 2013; 
Sarabdjitsingh et al., 2012).  While the hippocampus may be sensitive to genomic 
GR:MR imbalances, the amygdala may be sensitive to membrane-associated GR:MR 
balances.  Moreover, de Kloet (2014) has stated that the emotional processing of 
stressful stimuli occurs within seconds to minutes, potentially acting on mMR and 
mGR.  Consequently, the expression of mGR and mMR in the amygdala may add a 
new dimension to the receptor balance hypothesis. 
Summary and Implications 
In summary, stress can have a range of cognitive and behavioural effects 
(Santos et al., 2014; Vogel et al., 2014; Wingenfeld & Wolf, 2015; Zalachoras, 2014, 
which is believed to be mediated by two populations of corticosteroid receptors in 
the brain: GR and MR (Joels & Baram, 2009).  These corticosteroid receptors can 
have fast, membrane-associated effects or slow genomic effects within the nucleus 
(Groeneweg et al., 2012) but the relative distribution between these receptor 
subpopulations is still yet to be understood; especially within the subnuclei of the 
amygdala.  The amygdala has not been demonstrated to be sensitive to the receptor 
balance hypothesis, which typically focuses on genomic receptors (de Kloet, 2014).  
However, understanding the relative importance of these receptor subpopulations 
within the amygdala may add a new dimension to the receptor balance hypothesis, 
and help us to better understand the effects of stress.  
As of yet, there is no known differences in gene encoding or receptor 
structure between genomic and membrane-associated corticosteroid receptors (Prager 
& Johnson, 2009).  As such, the most optimal way of investigating these receptor 
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subpopulations was to visualise them.  Fogarty and colleagues (2013) developed a 
robust method of visualising the distribution of synaptic markers through 3D 
reconstruction.  The aim of this thesis was to test the feasibility and applicability of 
this approach to corticosteroid receptor, in order to characterise the distribution 
densities of GR and MR within the nucleus, and at post-synaptic sites. 
Firstly, we aimed to test the feasibility of using multiple label 
immunofluorescence to identify receptors located at excitatory post-synaptic sites.  
Previous studies have used immunofluorescence to characterise the distribution of 
steroid receptors at the membrane.  Schindelin et al. (2012) found, using electron 
microscopy, that not all inhibitory boutons contained estrogen receptors.  In order to 
investigate the amount of boutons that actually contained estrogen receptors, 
Schindelin and colleagues (2012) used immunofluorescence to differentially label 
GABA-boutons and estrogen receptors in rat hippocampal tissue.  Colocalisation of 
these markers allowed them to quantify the amount of inhibitory boutons that 
contained estrogen receptors.  In guinea pig corti tissue, Kil and Kalinec (2013) used 
confocal immunofluorescence to characterise the populations of genomic and 
membrane-associated GR and MR.  The researchers labelled corticosteroid receptors 
with a green fluorescent marker, and differentiated between the membrane and nuclei 
by labelling the actin in the plasma membrane with a red fluorescent marker, and the 
nuclei with a blue fluorescent marker.  Using this method, the researchers were able 
to visualise colocalisation between these markers, and subsequently quantify the 
different populations of GR and MR.  Based on these previous, studies, we used 
triple-labelling immunofluorescence as a method of differentiating between genomic 
and membrane-associated populations of GR and MR. 
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Secondly, we aimed to test the feasibility of adapting Fogarty’s approach to 
visualise GR and MR at different neuronal locations.  Electron microscopy studies 
have shown that membrane-associated receptors are located in the post synaptic 
density (PSD) at asymmetrical (excitatory) synaptic sites (L. R. Johnson et al., 2005; 
Prager et al., 2010) in the LA.  Interestingly, GR and MR were not found in all 
synapses (L. R. Johnson et al., 2005; Prager et al., 2010).  Using fluorescent markers, 
we labelled corticosteroid receptors and excitatory post-synaptic sites to determine 
what population of excitatory post-synaptic sites contained GR or MR.  Karst and 
colleagues (2010) have suggested that genomic and membrane-associated receptors 
may interact in a “yin-yang” fashion in the amygdala.  In order to better characterise 
genomic and membrane-associated populations, we also labelled nuclei within tissue 
sections to characterise the populations of gGR and gMR. 
Finally, we aimed to not only visualise the distribution, but to see if Fogarty’s 
approach could be used to potentially quantify these subpopulations of GR and MR.  
Most of the literature described uses traditional pixel-based methods of 
colocalisation, which is more prone to error than object-based methods of 
colocalisation (Lagache et al., 2015); and GR and MR data obtained from object-
based colocalisation is still lacking.  Moreover, there appears to be functional 
differences of membrane-associated GR and MR in the amygdala (Karst et al., 2010; 
Sarabdjitsingh & Joels, 2014; Sarabdjitsingh et al., 2012); however, relatively little is 
known about the distribution density in the different amygdala subnuclei.  As such, 
we were interested in testing the feasibility of using Fogarty’s approach to perform 
some preliminary analysis, on the volumetric densities of GR and MR in the 
amygdala, to further characterise these different subpopulations in stress-naive 
animals. 
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Chapter 3:  General Method 
In this thesis, I describe two studies we performed to characterise the 
distribution of GR and MR: the first study demonstrated the feasibility of using 
multiple labelling immunofluorescence to visualise the distribution of GR and MR; 
the second study adapted Fogarty’s approach to reconstruct the GR and MR for 
further analysis.  Both studies involved similar methods; thus in order to minimise 
repetition, this chapter describes the general materials and procedures shared by both 
studies.  Details specific to each study are provided in their respective chapters. 
In this chapter I begin by describing the animals used in the study.  I 
subsequently provide an overview of the antibodies and reagents used throughout the 
thesis, and review the specificity and sensitivity of the antibodies and their 
corresponding fluorescent labels.  In this chapter, I also describe the procedures 
involved: tissue preparation; corticosterone assay; immunohistochemistry; confocal 
imaging; and finally, image processing and analysis.  This chapter also includes the 
controls employed to ensure specificity of labelling, and provides operationalised 
definitions of the variables involved.  In the last section of this chapter, I discuss the 
ethical implications and application of animal research. 
Subjects 
The research was conducted on eight stress-naïve, male Sprague-Dawley rats 
sourced from University of Queensland Biological Resources (Queensland, 
Australia).  Rats were used as they provide a basic model for mammalian studies in 
neuroscience (Fogarty et al., 2013; Lupien & McEwen, 1997) and have displayed 
similarities to humans with respect to stress and memory (Lupien & McEwen, 1997; 
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Schwabe, 2013).  Rats were 20 weeks old, and weighed between 240g to 350g.  Due 
to sample attrition, three rats were used for protocol validation, and three rats were 
used to test the feasibility of three-dimensionally reconstructing corticosteroid 
receptors in the amygdala.  The sample size was in accordance with previous 
literature testing the feasibility of imaging techniques (Fogarty et al., 2013; 
Sarabdjitsingh, Meijer, & de Kloet, 2010; van Steensel et al., 1996) 
Rats were housed in a temperature-controlled room (24°C) maintained on a 
12hr/12hr light/dark cycle (6:30am-6:30pm).  There were two rats per cage and food 
and water were available ad libitum.  The animals were housed for seven days after 
arrival and handled for around five minutes every two to three days in order to 
habituate them to human handling (Deutsch-Feldman, Picetti, Seip-Cammack, Zhou, 
& Kreek, 2015).  All procedures were conducted in compliance with National Health 
and Medical Research Council (2013) as mandatory practice under the Queensland 
Animal Care and Protection Act (2016); all efforts were made to minimise animal 
suffering. 
Antibodies 
The density distributions of corticosteroid receptors have been shown to 
differ based on the antibody used (Sarabdjitsingh et al., 2010).  Moreover, some 
antibodies are better suited to detecting GR or MR in certain types of samples, e.g. 
tissue culture vs. fixed tissue compared to other (Sarabdjitsingh et al., 2010).  The 
reporting of antibodies used in research have been criticised for the lack of clarity 
(Bordeaux et al., 2010; Helsby, Fenn, & Chalmers, 2013).  As such, we described the 
biometric properties of the antibodies used, and reviewed their applicability to the 
current research in order to provide a standardised protocol for future studies. 
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Primary antibodies were raised in two different host species (Staines, Meister, 
Melander, Nagy, & Hökfelt, 1988); BuGR2 and rMR-1D5 antibodies were raised in 
mouse, and the anti-PSD-95 antibody was raised in rabbit.  Both secondary 
antibodies were raised in a different species to either primary antibody (Staines et al., 
1988).  The host species of the primary and secondary antibodies, as well as their 
antigens are summarised in Table 1.  Further details about the antibodies used (e.g. 
lot number) are available in Appendix A. 
Table 1 





BuGR2 rMR-1D5 PSD-95 
Host Species 
Mouse Mouse Rabbit 
Antigen 
Rat GR Rat MR Rat PSD-95 
 
Corresponding secondary antibody 
 






Mouse, anti-GR, BuGR2 (Thermofisher Scientific, Australia; catalogue 
number #MA1-510).  The BuGR2 is a primary antibody, against glucocorticoid 
receptor (Ahima & Harlan, 1990).  The BuGR2 antibody has been used to identify 
GR within the central nervous system of rodents(Adzic, Djordjevic, Demonacos, 
Krstic-Demonacos, & Radojcic, 2009; Virgonlini, Chen, Weston, Bauter, & A., 
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2005) and has shown consistent labelling in cell cultures and brain tissue 
(Sarabdjitsingh et al., 2010).  BuGR2 is a monoclonal antibody that has demonstrated 
high specificity towards GR; the epitope targets amino acids 407-423, close to the 
DNA binding domain (Ahima & Harlan, 1990; Howard, Holley, Yamamoto, & 
Distelhorst, 1990), but still discrete from the MR binding domain (Ahima & Harlan, 
1990).  Moreover, the BuGR2 antibody identifies both active and non-active sites (L. 
R. Johnson et al., 2005) and has identified GR in a number of locations including the 
nucleus and cytoplasm, at the synapse and within the neuropil (Ahima & Harlan, 
1990; L. R. Johnson et al., 2005).  The BuGR2 antibody has been used in 
fluorescence imaging (L. R. Johnson et al., 2005; Sarabdjitsingh et al., 2010), where 
increased immunoreactivity suggests increased receptor density (Ahima & Harlan, 
1990; L. R. Johnson et al., 2005).  In our current research, the BuGR2 antibody was 
used to identify GR populations within neurons. 
Mouse, anti-MR, rMR-1D5 (Developmental Studies Hybridoma Bank, 
IA, USA; catalogue #rMR1-18 1D5).  rMR-1D5 is a monoclonal, primary antibody, 
against mineralocorticoid receptor protein in rat, human and mouse (Gomez-Sanchez 
et al., 2006).  The rMR-1D5 has been demonstrated to be an accurate identifier of 
MR within rat brain tissue (Gomez-Sanchez et al., 2006) and has been used to label 
MR within the rat hippocampus (Gomez-Sanchez et al., 2006; Minuth, Denk, Hu, 
Castrop, & Gomez-Sanchez, 2007) and amygdala (Prager et al., 2010).  The epitope 
of rMR-1D5 targets amino acids 1-18 of the antibody domain (Gomez-Sanchez et al., 
2006; Prager et al., 2010), identifying both active and inactive MR (Prager et al., 
2010).  Aldosterone is the endogenous ligand for MR (Funder, 2005), however rMR-
1D5 has been demonstrated to label corticosterone-specific MR, as opposed to 
aldosterone-MR in rats (Prager et al., 2010).  rMR-1D5 identifies gMR, mMR, and 
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MR in the neuropil (Prager et al., 2010).  Increased immunoreactive labelling 
indicates increased concentration of MR protein (Minuth et al., 2007).  There has 
been limited research showing the use of rMR-1D5 in fluorescence microscopy.  
Thus, we standardised a protocol for the use of rMR-1D5 in immunofluorescence in 
Chapter 4 (protocol validation). 
Rabbit, anti-PSD-95 (Life Technologies, VIC, Australia; catalogue #51-
6900).  Most excitatory synapses have a pronounced post-synaptic density (Allison, 
Chervin, Gelfand, & Craig, 2000), and the PSD-95 protein is a prominent scaffolding 
protein specific to the post-synaptic density membrane (Hunt, Schenker, & Kennedy, 
1999; Niethammer, Kim, & Sheng, 1996).  Consequently, an anti-PSD-95 antibody 
was used as a membrane marker of excitatory post-synaptic terminals.  The anti-
PSD-95 antibody used in this study was a polyclonal antibody derived from the C-
terminal region of PSD-95 in humans, and has confirmed reactivity in rat tissue 
(Invitrogen, 2015).  This antibody was selected based on its host species, 
immunoreactivity and its application for fluorescence imaging (Invitrogen, 2015).  
The anti-PSD-95 primary antibody was raised in rabbit, thus limiting cross-reactivity 
between primary antibodies (Staines et al., 1988); moreover it has been used in the 
fluorescence imaging of neurons in rat tissue (Soria Van Hoeve & Borst, 2010).  
However, a Western blot has shown that this antibody has some cross-reactivity for 
an unknown protein at ~50kDa within rat brain homogenates (Invitrogen, 2015). 
Fluorescent Labels 
In order to visualise receptor localisation, fluorescent labels were used to 
mark the subcellular structures of interest (Daly & McGrath, 2003).  Primary 
antibodies were labelled with species-specific IgG (secondary antibody) coupled to a 
fluorochrome and nuclei were labelled with a fluorescent stain.  The sensitivity and 
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specificity of the reagents used described below.  The excitation and emission spectra 
for the fluorescent labels are shown in Figure 7. 
 
Figure 7.  Excitation and Emission Spectrum for DAPI, Alexa Fluor 488 and Alexa 
Fluor 594.  Adapted from Life Technologies (2015a). 
4′,6-diamidino-2-phenylindole (DAPI; Life Technologies, VIC, 
Australia).  DAPI is a blue fluorescent stain that binds to sites in the DNA 
(Kapuściński & Skoczylas, 1978; Life Technologies, 2015b) and has been used to 
identify the nuclei in the neurons within the amygdala (Y. Zhou et al., 2009).  DAPI 
had an excitation maximum of 358nm, and an emission maximum of 461nm 
(Invitrogen, 2006), displayed in Figure 7.  For the colocalisation of genomic 
receptors, DAPI was used to label nuclei within neurons. 
Goat Anti-mouse IgG, Alexa Fluor 488 (Abcam, VIC, Australia).  Both 
BuGR2 and rMR-1D5 have demonstrated high specificity to goat anti-mouse IgG 
coupled to an Alexa Fluor 488 fluorochrome (L. R. Johnson et al., 2005; Minuth et 
al., 2007).  Alexa Fluor 488 had an excitation maximum of 495nm and an emission 
maximum of 519nm (Abcam, 2015a)(displayed in Figure 7) labelling receptors in 
green.  The laser line of Alexa Fluor 488 was narrow, and relatively distinct from the 
other two fluorochromes used.  The bleed-through between the emission spectra of 
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Alexa Fluor 488 and DAPI (Figure 7) was controlled for by using sequential 
scanning (North, 2006). 
Goat, Anti-rabbit IgG, Alexa Fluor 594 (Abcam, VIC, Australia).  Goat, 
anti-rabbit IgG coupled to Alexa Fluor 594, was used to label the anti-PSD-95 
antibody.  The excitation maximum of Alexa Fluor 594 was 590nm and its emission 
maximum was 617nm (Abcam, 2015b), displayed in Figure 7.  The emission 
spectrum of Alexa Fluor 594 fluorochromes was quite separate from Alexa Fluor 




Animals were anaesthetised with ketamine/xylazine (1mg/kg/0.1mg/kg ip).  
Animals were subsequently transcardially perfused (Peristaltic Pump Model 3200, 
Welch-Ilmvac) with 200mL of physiological saline for 1 minute, and then perfused 
with 250mL of 4% paraformaldehyde (PFA; w/v) and 0.1M phosphate buffer (PB; 
v/v) in order to fix the brain tissue.  Brain tissue was removed from the animal and 
post fixed in 4% PFA in 0.1M PB for 4 hours and then washed in 0.1M phosphate 
buffer solution (PBS) three times at 10 minutes each.  Brains were placed in a 1mm 
rat brain matrix and sectioned on the coronal plane using the anterior and posterior of 
the mammillary bodies as a guide.  The tissue was attached to the specimen plate 
with cyanoacrylate adhesive and divided into two hemispheres.  Tissue was 
sectioned at 40µm using a vibratome and collected in PBS to be processed via 
immunochemistry. 
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Corticosterone Assay.  In order to ensure that animals were not stressed, the 
plasma concentration of corticosterone was determined for each rat using a 
competitive ELISA (Liston et al., 2013).  After rats were anaesthetised, blood 
samples were collected via cardiac puncture and incubated on ice.  Blood samples 
were collected at around ~12pm, at neither the peak or trough of the circadian cycle 
(Liston et al., 2013).  Blood samples were centrifuged for 20 minutes at 3500rpm, 
4°C, to separate the plasma fraction, which was aliquoted and stored at -80°C until 
assayed. 
The plasma concentration of corticosterone was measured using a 
commercial ELISA kit (Enzo Life Sciences, Catalogue #ADI-900- 097).  Before 
assay analysis, all plasma samples and kit reagents were brought to room 
temperature.  Samples were then diluted: first with steroid displacement reagent at a 
dilution of 1:2 (incubated for 10 minutes); and subsequently with assay buffer (final 
dilution 1:40).  Samples were loaded, in duplicate, into donkey, anti-sheep coated 
wells containing equal volumes of alkaline-phosphate conjugated corticosterone and 
sheep anti-corticosterone polyclonal antibody.  Samples were incubated in wells for 
2 hours, with agitation, at room temperature and were subsequently washed three 
times with wash buffer.  Wells were incubated with P-nitrophenyl phosphate 
(developer buffer) for 1 hour at room temperature and the reaction was stopped with 
trisodium phosphate.  The well-plate was measured using PHERAstar FS 
spectrophotometer (BMG Labtech, Germany) at an absorbance wavelength of 
405nm. 
Immunohistochemistry 
Free floating, hemispheric, coronal sections were blocked for 60 minutes with 
the blocking solution: 0.1M PBS, 1% Bovine Serum Albumin (BSA; w/v), 4% 
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Normal Goat Serum (NGS; v/v), 0.3% Triton-X 100 (v/v), 0.05% Tween-20 (v/v) to 
prevent non-specific binding (Burry, 2011).  A simultaneous double-staining 
protocol was used: the primary antibody for receptor type (BuGR2 or rMR-1D5) was 
applied to tissue slices at concentrations of 1:200, in conjunction with primary 
antibody PSD-95 (1:500) and incubated for 48 hours at 4°C.  Tissue was washed two 
to three times with the diluent buffer (0.1M PBS/1% BSA/4% NGS/0.3% Triton-X 
100/0.05% Tween-20), prior to the application of secondary antibodies.  Both 
secondary antibodies were applied simultaneously at a concentration of 1:400, and 
incubated for 3 hours before being washed two to three times in diluent buffer.  
DAPI was applied to the tissue at a concentration of 1:1000 for 10 to 15 minutes.  
The tissue was washed two times in diluent buffer, and then three times with PBS 
prior to mounting.  Tissue was mounted onto slides with Mowiol mounting medium 
and covered with No. 1.5 coverslips (Starfrost, Germany).  After the mounting 
medium had dried, slides were sealed using clear, non-fluorescent nail polish and 
stored at 4°C in the dark.  The optimisation of the protocol is described in more detail 
in Chapter 4 (protocol validation). 
Confocal Imaging 
Slides were imaged using an Olympus FV1200 Confocal Microscope 
equipped with 405nm, 473nm and 559nm solid state lasers; acquisition parameters 
are detailed in Appendix B.  Mosaic images were taken at 20× (0.86 NA) oil 
objective to accurately determine the presentation of the LA, BA and CeA regions 
for each section; two images were selected per region for quantification.  Images for 
quantification were taken at a resolution of 1024×1024, with a magnification of 60× 
(1.35 NA) oil objective and 2.5× sensor zoom, and a z-step of 0.3µm.  To avoid 
cross-talk (North, 2006), scanning was performed sequentially (473 and 405+559) 
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with a dwell time of 2µs/px.  Nyquist sampling theorem was used to ensure adequate 
sampling (North, 2006), and the sampling parameters (Appendix C) were within 1.7× 
the Nyquist calculations (Bolte & Cordelières, 2006).   
Image Processing 
Deconvolution techniques (here we used deconvolution to refer to both 
deconvolution and background correction algorithms) have been used to improve the 
Signal to Noise Ratio (SNR; i.e. the ratio between signal intensity to background 
intensity, where a higher ratio is preferred; Bolte & Cordelières, 2006), and the 
reliability of colocalisation analysis (Bolte & Cordelières, 2006; Zinchuk & 
Grossenbacher-Zinchuk, 2009).  Huygens Professional software (Scientific Volume 
Imaging) was used to reduce the amount of light scattering, and increase the SNR in 
confocal images (Bolte & Cordelières, 2006; Zinchuk & Grossenbacher-Zinchuk, 
2009).  The deconvolution parameters used, and the resulting images are described in 
more detail in Chapter 5.  Subsequent to deconvolution, the images were saved in the 
“Imaris Classic” file format for further processing in Imaris (Version 8.2, Bitplane). 
In order to perform the colocalisation analysis, subcellular structures were 
mapped and reconstructed in Imaris (Version 8.2, Bitplane) based on the methods by 
Fogarty et al. (2013).  As stated in Chapter 1, Fogarty et al. (2013) developed a 
robust method of reconstructing labelled synapses, and this approach can be used for 
to accurately perform colocalisation analysis.  We adapted this approach to measure 
colocalisation of corticosteroid receptors in different sub-cellular structures.  That is, 
GR or MR within nuclei or GR or MR colocalised with PSD-95.  The precise 
parameters are described in more detail within the results of Chapter 5 (corticosteroid 
receptor densities in the amygdala). 
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Design 
Controls 
Labelling Controls.  We firstly controlled for autofluorescence.  Brain tissue 
has endogenous fluorescence which can impact the quality of the fluorescent signal, 
and particulate autofluorescence can be incorrectly mistaken for labelling (Burry, 
2011).  Fixation techniques also present a potential threat to autofluorescence, 
increasing the background signal and lowering the SNR (Burry, 2011).  In order to 
control for autofluorescence, sections were blocked in blocking serum for one hour 
before being mounted on slides and observed with the same acquisition settings as 
experimental sections.  A lower signal indicated less autofluorescence. 
Single-label controls were used to characterise the labelling and to ensure that 
the labelling in triple-labelled sections was similar to that in single-label controls 
(Staines et al., 1988).  Single-label controls also served as a microscopy control to 
ensure that the fluorescent-label corresponded to the correct filter (North, 2006).  
Secondary-only controls were sections that omitted the primary antibody in order to 
characterise any non-specific labelling (Staines et al., 1988).  Sections were blocked 
and incubated in the secondary antibody (primary antisera were omitted).  There 
were three groups: sections that were incubated in goat, anti-mouse IgG Alexa Fluor 
488; sections that were incubated in goat, anti-rabbit IgG Alexa Fluor 594; and 
sections that were incubated in both secondary antisera. 
Secondary antibody controls.  Multiple labels were used, as such, it was 
necessary to confirm the specificity of the secondary antibody to its primary antibody 
(Burry, 2011; Staines et al., 1988).  The first secondary antibody control used a 
single-double labelling method (Burry, 2011) to test the specificity of the secondary 
antibody to the primary antibody.  Tissue sections were incubated with one primary 
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antibody, but stained with both secondary antibodies – groups summarised in Table 
2.  Specificity of the secondary antibody was determined by labelling in the channel 
congruent with the primary antibody and no labelling in the incongruent channel. 
Table 2 
A Summary of the Single-double Secondary Antibody Control 
Control Type Conditions First Primary Second Primary 
Experimental Primary BuGR2 or rMR-1D5 Anti-PSD-95 
 Secondary Alexa Fluor 488 Alexa Fluor 594 
 Label Expected Normal (Green) Normal (Red) 
    
No First 
Primary 
Primary None Anti-PSD-95 
Secondary Alexa Fluor 488 Alexa Fluor 594 
Label Expected None Normal (Red) 
    
No Second 
Primary 
Primary BuGR2 or rMR-1D5 None 
Secondary Alexa Fluor 488 Alexa Fluor 594 
Label Expected Normal (Green) None 
Note.  Adapted from “Controls for Immunocytochemistry: An Update,” by R. W. Burry, 2011, Journal 
of Histochemistry & Cytochemistry, 59, p. 11. 
The second secondary antibody control was to ensure there was no cross-
reactivity between antigen species (Burry, 2011).  This was done by staining the 
same tissue section with a primary antibody and its incongruent secondary antibody.  
In more detail, tissue stained with the primary antibody for receptor-protein (BuGR2 
or rMR-1D5) was labelled with Alexa Fluor 594, and tissue stained with the anti-
PSD-95 antibody was labelled with Alexa Fluor 488.  Labelling would indicate that 
cross-reactivity occurred between antibodies, and present as potential threats to the 
validity of the results. 
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Operationalisation of Variables 
Plasma Corticosterone Levels.  Plasma corticosterone levels were measured 
using an ELISA kit (procedure described above) to determine animal stress levels.  
Using Microsoft Excel, the absorbance values were averaged for each pair of wells.  
To calculate the net optical density, the average optical density from the “blank” and 
non-specific binding values were subtracted from the average optical density of 
bound wells.  Maximum binding wells and standard wells were used to generate a 
standard curve – creating a precision profile, and the absorbance values of the 
samples were plotted against this precision profile.  Corticosterone concentrations, 
were determined from the line of best fit, multiplied by the dilution factor (1:40) and 
expressed as ng/mL. 
Operationalisation of Amygdala Subnuclei.  The regions of interest (ROI) 
were the three subnuclei of the amygdala, LA, BA and CeA.  These subnuclei were 
identified using the topological layout of the amygdala in the rat brain atlas (Paxinos 
& Watson, 2007), displayed in Figure 8.  Sections were required to have all three 
structures on the same slice, limiting the sections to (anterior to posterior) Bregma –
2.04mm to -3.36mm (Paxinos & Watson, 2007).  Anatomical landmarks were used 
to determine the boundaries of the LA; the external capsule was the lateral boundary 
of the LA; the striatum (Olucha-Bordonau, Fortes-Marco, Otero-Garcia, Lanuaz, & 
Martinez-Garcia, 2015) and the ITC as the medial boundaries of the LA.  This 
involved all subregions (Olucha-Bordonau et al., 2015), presented in the rat brain 
atlas as dorsal lateral (LaDL), ventral medial (LaVM), dorsal ventral (LaVL) 
(Paxinos & Watson, 2007).  The BA was operationalised as the basolateral amygdala 
anterior part (BLA) and posterior part (BLP) (Paxinos & Watson, 2007).  The BA 
was directly ventral to the LA, and bordered laterally by the external capsule.  As the 
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boundary between the LA and the BA was not always distinct, we sampled from the 
most ventral parts of the BA, using the most ventral part of the external capsule as a 
guide.  The CeA presented as a ring-like structure adjacent to the BLA-complex 
(Olucha-Bordonau et al., 2015).  The CeA has been further subdivided into central 
amygdala central, central amygdala lateral, and central amygdala medial (Sah et al., 
2003), which are abbreviated in the rat brain atlas as CeC, CeL, CeM, respectively 
(Paxinos & Watson, 2007).  For the current study, we did not differentiate between 
the CeC, CeL and CeM, and operationalised all three sub-regions as the CeA. 
 
 
Figure 8.  The LA, BA and CeA in a coronal section, regions sampled in grey.  Sections 
were taken -2.04mm to -3.36mm from the bregma according to the rat brain atlas 
(Paxinos & Watson, 2007).  Adapted from “The Rat Brain in Stereotaxic Coordinates 
6th edition,” by G. Paxinos and C. Watson, 2007, p.56. 
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Corticosteroid receptors.  The labelling of corticosteroid receptors (GR or 
MR) was varied between groups.  That is, tissue was either incubated with the 
BuGR2 or rMR-1D5 primary antibody.  As both BuGR2 and rMR-1D5 were raised 
in mouse, they were labelled with the same secondary antibody: goat, anti-mouse 
IgG Alexa Fluor 488.  Both groups had tissue from the same rats and tissue sections 
were assigned as GR sections or MR sections by alternating serial slices.  Both GR 
and MR sections were processed in parallel, and all other labels were consistent 
across groups.  The acquisition settings were slightly different for GR and MR.  That 
is, the laser power, offset, and gain for the 473nm laser, was varied between GR 
sections and MR sections. 
Parameters of nuclei and excitatory post-synapses.  Corticosteroid 
receptors (GR or MR) were labelled using green fluorescent markers (IgG Alexa 
Fluor 488).  Excitatory post-synaptic terminals (PSD-95) were labelled using a red 
fluorescent marker (IgG Alexa Fluor 594).  Nuclei were labelled using DAPI, a blue 
fluorescent marker.  Filters were set to detect the emission wavelength of 
corticosteroid receptors between 527nm to 583nm, PSD-95 labelling was read at 
668nm, and DAPI-labelled nuclei were read at 461nm.  Channels were pseudo-
coloured as green, red and blue respectively. 
Volumetric quantification of colocalised corticosteroid receptors, was 
performed in Imaris (Bitplane, Version 8), using Fogarty’s approach and were 
operationalised based on the 3D objects rendered in Imaris (Bitplane).  Nuclei were 
reconstructed as “surfaces”.  GR, MR and PSD-95 puncta were reconstructed as 
“spots”.  The parameters are described in more detail in Chapter 5.  In order for 
puncta-labelling to be reconstructed as spots, Fogarty’s approach had two criteria 
that needed to be met: a) spot-like labelling needed to be well defined, with a 
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minimum of diameter of 0.25µm; and b) the signal intensity of the puncta needed to 
be strong enough, relative to the background, for the software to accurately 
demarcate between labelling and noise (Fogarty et al., 2013). 
Corticosteroid receptor-like spots, inside of nuclei surfaces, were classified as 
genomic GR spots or genomic MR spots.  Receptor-like spots outside of nuclei 
surfaces were operationalised as extra-nuclear GR spots or extra-nuclear MR spots.  
Corticosteroid receptor-like spots, colocalised with PSD-95 spots were referred to as 
colocalised spots. 
Parameters for colocalisation.  Colocalised objects were calculated using 
the nearest-neighbour distance approach (Bolte & Cordelières, 2006).  That is, 
objects are deemed to be colocalised if they are within a predetermined distance to 
each other.  Distances are calculated between the centres of two objects 
(Lachmanovich et al., 2003).  Thus, a maximum distance of 0µm assumes a complete 
overlap between the centre points of the receptor spot and the PSD-95 spot.  While 
corticosteroid receptors have been found to be located within the PSD (L. R. Johnson 
et al., 2005; Komatsuzaki et al., 2012; Prager et al., 2010), it was not necessarily the 
case that the centres of both spot objects would completely overlap.  As such, a 
distance of 0µm was too stringent and would lead to underestimating the degree of 
colocalisation.  Instead, the maximum distance between two objects was set at 
0.1µm.  This was because the smallest structures were receptors spots, which had a 
diameter of 0.2 µm and a threshold of 0.1µm ensured that at least half of the smallest 
object would be covered (Lachmanovich et al., 2003). 
Statistical Analysis.  Data was extracted from Imaris (Bitplane, Version 8) 
into Microsoft Excel.  Statistical analysis was performed in SPSS, and statistical 
significance was accepted as p < 0.05. 
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Ethics and Limitations 
Ethics and Handling 
All procedures were approved by the University Animal Ethics Committee at 
The University of Queensland, under the Approval Number: TRI/QUT/262/15/IHBI; 
and by the University Animal Ethics Committee from Queensland University of 
Technology under Approval Number: 1500000739, see Appendix D.  As stated in 
the Subjects section, all research was conducted in compliance with Australian code 
for the care and use of animals for scientific purposes 8th Edition (2013) as embodied 
in the Queensland Animal Care and Protection Act (2016). 
Handling-induced stress has been demonstrated to significantly increase 
corticosterone levels in rats (Balcombe, Barnard, & Sandusky, 2004).  As our study 
aimed to understand corticosteroid receptors in stress-naive animals, handling-
induced stress threatened the validity of the study.  Playful handling is a method that 
has been shown to decrease the emotional stress displayed by rats, as well reduced 
fear towards experimenters (Cloutier, Panksepp, & Newberry, 2012).  In order to 
control for handling-associated stress, playful handling was used to habituate the rats 
to the experimenter and decrease variability in corticosterone levels (Deutsch-
Feldman et al., 2015).  Additionally, a corticosterone assay was performed to 
confirm animals were not stressed. 
The applicability of Animal Research to Humans in Stress 
At first glance, rodents and humans appear quite different, thus the use of 
animals presented as a potential threat to the validity of the study.  The primary 
ligand for GR and MR differs between rodents and humans (Prager & Johnson, 
2009).  In rodents, corticosterone is the primary stress hormone released in rats, 
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whereas in humans, cortisol is the primary stress hormone (de Kloet, 2014).  
However, cortisol and corticosterone are chemically similar, and corticosterone has 
also been found in human brain tissue (Karssen et al., 2000).  Furthermore, rodent 
models of GR and MR have been shown to have structural and functional similarities 
compared with humans.  Humans and rodents have displayed high expressions of GR 
and MR in the brain (Reul & de Kloet, 1985; Seckl, Dickson, Yates, & Fink, 1991; 
Q. Wang et al., 2014), although the subregional distributions have been shown to 
differ between species (Seckl et al., 1991).  The behavioural and cognitive data of 
both humans and rats, in response to corticosteroids, suggest that animal models have 
at least some applicability to humans (Lupien & McEwen, 1997; Schwabe, 2013).  In 
accordance with behavioural changes, corresponding biological changes to GR and 
MR expression have been demonstrated in rats and humans (López, Chalmers, Little, 
& Watson, 1998; Schwabe, 2013).  Although there are physiological differences, the 
evidence would suggest that rodent models can be used to provide an understanding 
of GR and MR populations. 
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Chapter 4:  Protocol Validation 
Immunofluorescence has been used in previous research to characterise the 
densities of GR and MR in neurons (Han et al., 2014; van Steensel et al., 1996).  
However, in order to view mGR and mMR labelling at excitatory post-synaptic 
terminals, we needed to perform fluorescence imaging at a higher resolution than 
previous studies investigating density.  Although GR- and MR-labelling have been 
previously observed at the post-synaptic density under the electron microscope (L. R. 
Johnson et al., 2005; Prager et al., 2010), it was unknown if the corticosteroid 
receptor labels would be colocalised with the PSD-95 labels.  Moreover, in order to 
perform the 3D reconstruction of “spots” for colocalisation analysis, the labelling of 
corticosteroid receptor proteins needed to meet certain criterion (Fogarty et al., 
2013).  Thus, the aim of the study was two-fold: first, we wanted to test the 
specificity of the labels and optimise the reagents for triple-labelling 
immunofluorescence; second, we wanted to determine if the characterisation of the 
labelling was suitable for Fogarty’s approach.  The first part of this chapter describes 
the methods used to validate the protocol and the reagents.  Subsequently, the results 
are displayed in the form of representative images, and their implications discussed. 
Method 
Subjects and Procedure 
Four Sprague-Dawley rats, weighing between 250g to 350g, were housed for 
one week (more details are provided in Chapter 3).  Animals were handled during the 
week in order to familiarise them to the researchers, and reduce stress (Cloutier et al., 
2012).  All procedures were approved by the animal ethics committee for 
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Queensland University of Technology, and The University of Queensland (Appendix 
D). 
Some tissue was lost in processing; as such, samples were obtained from 
three Sprague-Dawley rats.  Rats were transcardially perfused with 0.9% saline 
solution, followed by 250ml of 4% PFA (w/v) in 0.1M PB.  Tissue was post-fixed 
for 4 hours and cut using a vibratome (Pelco Easislicer) at 40m to 60m thick 
sections.  Immunohistochemistry was performed as described in Chapter 3.  Sections 
were incubated in a blocking buffer for 1 hour at room temperature, and primary 
antisera was incubated between 24 to 48 hours at 4°C depending on the condition.  
After the washing step, tissue was incubated in secondary antisera (1:400) between 2 
to 4 hours at room temperature, depending on the condition.  Some sections were 
incubated in DAPI (1:1000) for ~15 minutes and washed three times in PBS before 
being mounted onto slides.  Slides were mounted with Mowiol and covered with No. 
1.5 coverslips (Starfrost, Germany). 
Sections were imaged using an Olympus IX73 epifluorescent microscope 
equipped with a metal halide lamp, in three channels (Emissionmax/Absorbancemax): 
DAPI (350/455), GFP (470/510), and cy3 (560/656).  In order to observe puncta 
labelling, images were taken using a 60× (1.25 NA) oil objective.  Multi-channel 
images were manually captured in sequence: first in the GFP channel, then the cy3 
channel and finally the DAPI channel.  Some sections were further imaged on the 
confocal microscope to determine if the resolution would be suitable for further 
analysis. 
Epifluorescent images were taken using a XM10 monochrome camera.  As 
such, all images were pseudo-coloured and adjusted for brightness and contrast in 
Fiji (Schindelin et al., 2012).  GR- or MR-like labelling was pseudo-coloured green, 
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PSD-95-like labelling was pseudo-coloured red and DAPI-labelling was pseudo-
coloured blue.  Epifluorescent images were merged in Fiji (Schindelin et al., 2012) 
using the merge channels function.  Images were arranged for display using Adobe 
Photoshop CS6. 
Design 
Anti-PSD-95 Titration.  Protocol optimisation for the anti-PSD-95 primary 
antibody was based on the supplier’s recommended dilutions for 
immunofluorescence (Invitrogen, 2015).  Sections were incubated for 24 hours at 
4°C, with anti-PSD-95 antibody and diluted with 0.1M PBS/1% BSA/4% NGS/0.3% 
Triton-X 100/0.05% Tween-20.  Dilutions were performed at 1:500, 1:750 and 
1:1000. 
rMR-1D5 Titration.  The immunofluorescent protocol for the MR primary 
antibody, rMR-1D5, was not well established in the literature compared to the 
primary GR antibody, BuGR2 (Gomez-Sanchez et al., 2006).  In order to optimise 
the labelling and provide a standardised protocol, titrations were conducted for the 
MR antibody, rMR-1D5, and diluted in 0.1M PBS/1% BSA/4% NGS/0.3% Triton-X 
100/0.05% Tween-20.  An epifluorescent microscope was used to image all groups, 
and the conditions that displayed the best labelling were further examined under the 
confocal microscope. 
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Figure 9.  Groups involved in MR titration of antibodies 
Titrations were done at dilutions of 1:200, 1:500 and 1:1000 and 60m thick 
sections were incubated for 24 hours or 48 hours at 4°C.  The secondary antibody 
incubation time was also varied, at 2 hours and 4 hours.  A summary of these groups 
can be seen in Figure 9. 
Buffers.  Two different protocols were used.  The first protocol was based on 
the protocol described in Prager et al. (2010); tissue was blocked with 1% BSA (w/v) 
in 0.1M PBS, antibodies were diluted with 0.1M PBS, 0.3% Triton-X 100 (v/v) and 
the washed with 0.1M PBS.  The second protocol used a blocking serum that not 
only blocked for the primary IgG, but also the secondary IgG to improve specificity 
(Xing, 2007).  The blocking serum was 0.1M PBS, 1% BSA (w/v), 4% NGS; (v/v), 
0.3% Triton-X 100 (v/v), 0.05% Tween-20 (v/v).  This solution was also used as the 
diluent buffer and the wash buffer. 
Controls.  Controls were performed as described in Chapter 3.  Firstly, 
autofluorescence controls were performed in order to determine the amount of 
endogenous background fluorescence from the tissue.  Secondly, single label 
controls were imaged.  For single-label controls, sections were incubated with one 
primary antibody and its corresponding secondary antibody.  Labelling of single-
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label controls was compared to secondary-only controls and cross-reactivity controls 
to determine the specificity of the fluorescent label to the primary antibody (Burry, 
2011). 
Triple-labelling.  All sections were stained for PSD-95 immunoreactivity 
and DAPI.  However, corticosteroid receptor labelling was varied between groups.  
Tissue was either incubated with the BuGR2 or rMR-1D5 primary antibody, which 
we refer to as GR sections or MR sections respectively.  Triple labelling was initially 
characterised using the epifluorescent microscope.  Upon confirmation of labelling, 
sections were further imaged at a higher resolution, under the confocal microscope to 
ensure that labelling met the criterion for 3D spot reconstruction according to 
Fogarty et al. (2013). 
Results and Discussion 
Reagent optimisation 
PSD-95 Titration.  Titrations were conducted for the anti-PSD-95 primary 
antibody at dilutions of 1:500, 1:750 and 1:1000.  Under the epifluorescent 
microscope, a dilution of 1:500 provided the strongest labelling, but also had a 
relatively higher background signal compared to the other dilutions (Figure 10).  The 
best SNR under the epifluorescent microscope was seen at a dilution of 1:750.  
Under the confocal microscope, there was limited background at a concentration of 
1:500.  Sections incubated at a concentration of 1:500 showed good penetration of 
the antibody and required less laser power and exposure time.  As a result, the anti-
PSD-95 primary antibody was diluted at a concentration of 1:500 in Chapter 5. 
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Figure 10.  Representative image of fluorescent labelling of PSD-95-like 
immunoreactivity at concentrations of 1:500, 1:750 and 1:1000 (epifluorescence), in 
rat brain tissue.  A non-linear contrast was applied in Photoshop using the curves 
function.  Transformation was applied uniformly to all three images to improve the 
contrast.  Images were taken with a 60x (1.25 NA) oil objective.  Scale bar: 10µm 
MR Titration.  In order to optimise the fluorescence labelling for rMR-1D5, 
the concentration and incubation time of the primary antibody, rMR-1D5 was varied, 
as was as the incubation time of the secondary antibody, IgG Alexa Fluor 488.  
Observation under the epifluorescent microscope showed that an incubation time of 4 
hours for the secondary antibody provided the strongest labelling, regardless of the 
primary antibody conditions, albeit with higher amounts of background noise (Figure 
11b, 11c and 11d).  At an incubation time of 24 hours, the dilution that provided the 
strongest labelling was 1:200, while still having a relatively little background (Figure 
11a and 11b).  An incubation time of 48 hours had clearer labelling at dilutions of 
1:200 and 1:500, compared with an incubation time of 24 hours (Figure 11).  The 
background labelling at 1:500 was relatively reduced compared to 1:200 (Figure 11f 
and 11d respectively), however, the puncta labelling at 1:200 was a lot stronger.  As 
the strongest labelling of rMR-1D5 was at 1:200 for 48 hours, these sections were 
further examined using the confocal microscope to confirm if they met the criterion 
for spot creation (Fogarty et al., 2013). 
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Figure 11.  a), b), c), and d) show tissue sections incubated with rMR-1D5 at a 
dilution of 1:200; where the top two images are sections incubated for 24 hours, 
and the middle two images are sections incubated for 48 hours.  Images e) and f) 
were diluted at 1:500 incubated for 48 hours.  Images in the left column have been 
incubated for 2 hours with the secondary antibody and images in the right column 
have been incubated for 4 hours.  Epifluorescent images were taken with a 60x 
(1.25 NA) oil objective.  Scale bar: 10µm 
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Sections incubated in rMR-1D5 at 1:200 for 48 hours were examined under 
the confocal microscope.  Contrary to the epifluorescent microscope, the best SNR 
was seen when the secondary antibody was incubated at 2 hours instead of 4 hours, 
displayed in Figure 12.  Although the puncta staining was stronger in the 4-hour 
condition, the background labelling was also a lot stronger.  Based on this, we 
decided to use an incubation time of 3 hours for the secondary antibody in Chapter 5.  
In addition, the use of 60m thick sections could have contributed to the high 
background noise.  This was also corrected in Chapter 5 by reducing the thickness of 
the tissue sections. 
Punctate labelling was observed in clusters within the nuclei, but also 
sparsely scattered throughout the section (Figure 12).  MR-like puncta were 
measured to have a diameter between 0.3m to 0.5m; thus meeting the minimum 
criterion for Fogarty’s approach (Fogarty et al., 2013).  It was interesting to note that 
MR-like puncta in the nucleus, but in some nuclei, MR-like labelling appeared to be 
homogenously distributed within the nucleus.  The homogenous labelling provided a 
potential threat to later spot creation.  As extra-nuclear MR-like labelling was 
distinctly punctate, Fogarty’s approach could still be used for colocalisation analysis.  
No labelling was seen within the nucleolus (Figure 12) which was consistent with 
previous literature (van Steensel et al., 1996). 
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Figure 12.  Confocal imaging of rMR-1D5 labelled slices at a concentration of 1:200 
with an incubation time of 48 hours.  Tissue sections were incubated with IgG Alexa 
Fluor 488 for 2 hours (a) or 4 hours (b).  Images were taken with a 60x (1.35 NA) oil 
objective with 2.5x sensor zoom.  Scale bar: 10µm 
Buffer comparison.  The more sophisticated diluent buffer appeared to have 
less non-specific labelling at the surface of sections.  Antibody penetration also 
appeared to be better when using the more sophisticated diluent buffer.  As a result, 
the buffer solution comprising of 0.1M PBS, 1% BSA (w/v), 4% NGS (v/v), 0.3% 
Triton-X 100 (v/v) and 0.05% Tween-20 (v/v), was used in Chapter 5. 
Labelling Specificity 
Autofluorescence.  Autofluorescence was uniformly diffused across the 
tissue.  At higher magnifications, some particulate autofluorescence could be seen, 
but it was quite dim.  As the autofluorescence of the tissue was relatively dim, the 
same fixation parameters were used in the study conducted in Chapter 5. 
Specificity of Fluorescent Labels.  Single-label controls consisted of 
sections incubated with one primary antibody and its congruent secondary antibody.  
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The labelling of these sections was compared to secondary-only controls and cross-
reactivity controls.  Both GR-like and MR-like labelling was observed in single-label 
controls (Figure 13a and 13b).  Comparatively, secondary-only controls displayed 
minimal immunoreactivity outside of background labelling (Figure 13).  It should be 
noted that background labelling in the GFP channel of secondary-only controls was 
still brighter than autofluorescence.  Finally, cross-reactivity controls revealed 
limited cross reactivity.  Random blebs could be seen but they were not characteristic 
of GR-like or MR-like labelling (Figure 13e and 13f).  Moreover, the blebs appeared 
to be present only at the surface of the sections and were not seen in the middle of 
the slice. 
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Figure 13.  Control sections, sample: rat brain tissue.  Single-label controls for GR (a) 
and MR (b) in the GFP channel, green.  Figures (c) and (d) show secondary-only 
controls of GR and MR respectively.  Images (e) and (f) show the cross-reactivity 
controls for GR and MR respectively, in the cy3 channel.  Epifluorescent images 
were taken with a 60x (1.25 NA) oil objective.  Scale bar: 10µm 
Accordingly, single-labelled sections for excitatory post-synapses revealed 
PSD-95-like immunoreactivity.  PSD-95-like labelling was consistent with previous 
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literature, and presented as puncta-shaped labelling (Fogarty et al., 2013) distributed 
throughout the amygdala (Hunt et al., 1999), see Figure 14a.  Secondary-only 
controls (sections incubated in goat, anti-rabbit IgG, Alexa Fluor 594) displayed 
minimal immunoreactivity and no punctate staining was observed (Figure 14b).  This 
suggests the labelling of the secondary antibody is specific to PSD-95.  Cross-
reactivity controls also did not show any puncta staining in the GFP channel (Figure 
14c) further suggesting the specificity of the secondary label. 
 
Figure 14.  Single-label control in rat brain tissue, for anti-PSD-95 shows puncta 
labelling (a) with cy3 filter.  Alexa Fluor 594, secondary-only control (b) with cy3 
filter shows minimal labelling.  Cross-reactivity control for anti-PSD-95 primary 
antibody (c) shows minimal immunoreactivity in GFP channel.  Epifluorescent 
images were taken with a 60x (1.25 NA) oil objective.  Scale bar: 10µm 
We also found that single-label controls only displayed labelling in their 
respective channels.  This suggested that there was no bleed-through between 
channels (North, 2006).  Tissue incubated with both secondary antisera (primary 
antisera omitted) also showed minimal immunoreactivity in the GFP and cy3 
channels, further supporting the specificity of the fluorescent labels. 
Single-double labelling.  In order to test the specificity of the secondary 
antibodies to each primary antibody, tissue was incubated in one primary antibody 
and both secondary antibodies (Burry, 2011), displayed in Figure 15.  Tissue 
incubated in primary antiserum, BuGR2, showed GR-like labelling under the GFP 
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channel and minimal labelling in the cy3 channel, similar to the cross-reactivity 
controls.  Similarly, tissue incubated in the primary antiserum rMR-1D5 also showed 
MR-like labelling under the GFP channel and limited labelling the cy3 channel.  It 
was observed that the GR- and MR-like labelling was brighter in the GFP channel 
compared to single label controls.  No labelling was observed for the PSD-95 single-
double control for either channel. 
 
Figure 15.  Epifluorescent images of brain tissue sections labelled with one primary 
antibody and both secondary antibodies: GR single-double control in the (a) GFP 
channel (green), and (b) cy3 channel (red); MR single-double control in the (c) GFP 
channel (green) and the (d) cy3 channel (red).  Images were taken with a 60x (1.25 
NA) oil objective.  Scale bar: 10µm 
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Characterisation of Triple Labelling 
Fluorescent Labelling in GR sections.  We were interested in characterising 
the appearance of triple-labelling in GR sections.  Tissue sections were initially 
imaged using the epifluorescent microscope (Figure 16).  GR, PSD-95 and DAPI 
immunoreactivity was seen in the GFP, cy3 and DAPI channel respectively.  GR-like 
labelling was seen within the nucleus and distributed throughout the amygdala 
(Figure 16a).  GR-like labelling was distinctly punctate shaped and clustered within 
the nucleus (Figure 16d). 
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Figure 16.  Triple labelling for GR sections in rat brain tissue, under the 
epifluorescent microscope.  For the same region, in the GFP channel (green) GR-like 
immunoreactivity was observed (a).  In the cy3 channel (red) PSD-95-like labelling 
was seen (b).  In the DAPI channel (blue) nuclei-labelling was seen (c).  All three 
channels were artificially merged (d).  Images were taken with a 60x (1.25 NA) oil 
objective.  Scale bar: 10µm 
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In order to see if GR was colocalised with PSD-95, higher resolution images 
were captured under the confocal microscope.  Under the confocal microscope, GR-
like labelling presented as well defined puncta, both within the nucleus and 
distributed throughout the section, which was consistent with previous research 
(Sarabdjitsingh et al., 2010).  The diameter of GR-like puncta were around 0.2µm to 
0.7µm, similar to that in previous literature (van Steensel et al., 1996).  Moreover, 
puncta labelling was relatively distinct from the background, meaning that GR-like 
labelling was suitable for 3D reconstruction (Fogarty et al., 2013).  The diameter of 
PSD-95-like punctate were measured to be between 0.3µm to 0.7µm, which was in 
accordance with previous research (Hunt et al., 1999).  Additionally, PSD-95-like 
puncta were well defined, and also met the criterion for spot quantification (Fogarty 
et al., 2013).  GR-like labelling appeared to overlap with PSD-95-like labelling, 
which was indicated by yellow fluorescence (white arrows in Figure 17).  Some 
PSD-95-like labelling was found inside the nuclei.  As stated in Chapter 3, this 
particular anti-PSD-95 antibody has displayed some cross-reactivity within rat 
homogenates (Invitrogen, 2015).  This was controlled for during analysis by 
excluding any labelling within nuclei. 
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Figure 17.  Confocal imaging of GR-section in rat brain tissue.  GR-like labelling can 
be seen in green, PSD-95-like labelling in red, and DAPI labelling in blue.  
Colocalisation of GR-like labelling with PSD-95 like labelling is shown in yellow 
(indicated by white arrows).  Images were taken with a 60x (1.35 NA) oil objective 
with 2.5x sensor zoom.  Scale bar: 10µm 
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Fluorescent labelling in MR sections.  We were also interested in testing 
whether triple-labelling fluorescence on MR sections was a suitable for use with 
Fogarty’s approach.  Labelling in MR sections were initially characterised using the 
epifluorescent microscope (Figure 18).  MR-like immunoreactivity was not as 
intense as GR-like immunoreactivity.  Moreover, the labelling of MR-like structures 
was not as well defined as GR-like structures.  Some neurons displayed homogenous 
distribution of MR-like labelling within the nucleus.  The DAPI and PSD-95-like 
labelling was similar to labelling seen in GR sections, suggesting that the staining 
conditions of DAPI and PSD-95 were constant between GR and MR sections. 
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Figure 18.  Triple labelling for MR sections in rat brain tissue, under the 
epifluorescent microscope.  a) In the GFP channel (green) MR-like immunoreactivity 
was seen.  b) In the cy3 channel (red) PSD-95-like labelling was seen.  c) In the DAPI 
channel (blue) nuclei-labelling was seen.  d) All three channels were artificially 
merged.  Images were taken with a 60x (1.25 NA) oil objective.  Scale bar: 10µm 
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Further examination under the confocal microscope showed MR-like 
structures were not as distinct as GR-like structures (Figure 19).  MR-like puncta 
labelling could be seen, distributed throughout the section.  Moreover, MR-like 
puncta showed some overlap with PSD-95-labelling (indicated by white arrows in 
Figure 19).  Within the nucleus, MR-like puncta could be seen, however, they were 
not well defined.  Moreover, MR-like labelling in the nucleus was more 
homogenously distributed which made it difficult to threshold MR-like puncta in the 
nucleus.  In the literature, MR-like labelling in the nucleus appeared to be more 
variable.  Some research displayed MR-like labelling to be distinctly puncta shaped 
(Kil & Kalinec, 2013; van Steensel et al., 1996), while others suggested that MR 
labelling had a relatively homogenous distribution within nuclei (Groeneweg, 2014).  
MR-labelling has also been reported to have a higher distribution within the 
cytoplasm compared to GR-labelling (Han et al., 2014). 
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Figure 19.  Confocal imaging of MR-section in rat brain tissue.  MR-like labelling can 
be seen in green, PSD-95-like labelling in red, and DAPI labelling in blue.  The nuclei 
labelling was selected for optimal MR labelling – the DAPI labelling is not 
representative of the DAPI nuclei staining obtained throughout.  Colocalisation of 
MR-like labelling with PSD-95 like labelling is indicated with white arrows.  Images 
were taken with a 60x (1.35 NA) oil objective with 2.5x sensor zoom.  Scale bar: 
10µm 
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Summary 
Previous studies have used triple-labelling immunofluorescence as a method 
of distinguishing between different subcellular populations of GR and MR in other 
cell types (Kil & Kalinec, 2013).  In this study, we aimed to test the feasibility of 
using triple-labelling to characterise the populations of GR and MR in brain cells and 
whether the labelling would be suitable for 3D reconstruction in Imaris.  As the 
validity of the primary antibodies used had been well characterised (Ahima & 
Harlan, 1990; Gomez-Sanchez et al., 2006), we aimed to optimise the protocol for 
multiple labelling immunofluorescence.  A titration of the anti-PSD-95 antibody 
revealed good penetration and labelling at a dilution of 1:500.  Titration of the 
primary MR antibody, rMR-1D5, showed the best puncta labelling at a dilution of 
1:200 and an incubation time of 48 hours. 
Next we tested the specificity of the fluorescent labels.  Single-label controls 
revealed labelling of GR- and MR-like structures that was similar to previous 
research (Groeneweg, 2014; L. R. Johnson et al., 2005; Prager et al., 2010; van 
Steensel et al., 1996).  Autofluorescence controls and secondary-only controls had 
limited immunoreactivity, suggesting that the labelling seen was not merely an 
artefact produced by the secondary antibodies (Burry, 2011).  Cross-reactivity 
controls revealed limited labelling, suggesting that the fluorescent labels were 
specific to the primary antibody.  Single-double controls further supported the 
specificity of the secondary label to its corresponding secondary antibody. 
Finally, we described the triple-labelling for GR and MR sections.  GR- and 
PSD-95-like structures presented as well defined puncta, with a minimum diameter 
above 0.2m; meeting the criteria for spot reconstruction (Fogarty et al., 2013).  
Extra-nuclear MR-like structures also had well defined puncta and met the criteria 
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for reconstruction and colocalisation analysis (Fogarty et al., 2013).  However, MR-
like puncta within nuclei was not as well defined and presented a potential threat to 
the reconstruction and quantification analysis.  Confocal imaging also showed that 
both GR and MR sections showed some overlap in the fluorescence signals of 
receptor-like labelling and PSD-95-like labelling.  This suggested that GR- and MR-
like structures may be colocalised with PSD-95-like structures. 
Based on these results we were able to confirm the use of the reagents for 
visualising GR-like and MR-like structures in fixed brain tissue.  Moreover, puncta 
labelling for GR, PSD-95 and extra-nuclear MR clearly met the criterion for 
Fogarty’s approach (Fogarty et al., 2013), although nuclear MR structures were less 
well defined.  Thus, we were able to establish a standardised protocol for triple-
labelling immunofluorescence of corticosteroid receptors to be used in colocalisation 
analysis in Chapter 5. 
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Chapter 5:  Corticosteroid Receptor Densities in the Amygdala 
The neuronal distribution of corticosteroid receptors in the amygdala have 
been described in previous studies (Ahima & Harlan, 1990; Ahima et al., 1991; 
Morimoto et al., 1996), however the distributions of mGR and mMR are still being 
characterised.  In the LA, mGR and mMR have been found in the PSD at some 
synapses (L. R. Johnson et al., 2005; Prager et al., 2010), but the overall distribution 
of mGR and mMR located at post-synaptic sites is unclear.  In this chapter, we used 
the method developed in Chapter 4 for confocal imaging, and we adapted Fogarty’s 
approach to reconstruct the labelled structures for colocalisation analysis (Fogarty et 
al., 2013).  Using this approach, we were interested in obtaining preliminary data for 
the characterisation of GR and MR at excitatory post-synaptic sites within the 
different subnuclei of the amygdala. 
This chapter begins with an overview of the methods used.  This involves the 
parameters for deconvolution using Huygens Professional Software (Scientific 
Volume Imaging), and the 3D reconstruction of fluorescent structures in Imaris 
(Version 8.2, Bitplane).  Subsequently we present the results of adapting Fogarty’s 
approach to GR and MR fluorescent labelling, and provide detailed instructions of 
the process used.  Finally, we used the data obtained from 3D reconstruction to 
perform some preliminary calculations on the distribution densities of GR and MR in 
the amygdala. 
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Method 
Subjects and Procedure 
Tissue was collected from four Sprague-Dawley rats (255-260g), although some 
samples were lost during processing.  As such, the final analysis was performed on 
three animals.  This was still a reasonable sample size for a feasibility study using 
stress naïve animals, and was in accordance with similar research (Fogarty et al., 
2013; Sarabdjitsingh et al., 2010; van Steensel et al., 1996). 
Animals were acclimatised to the environment for one week prior to any procedures.  
Housing conditions and handling procedures are described in more detail in Chapter 
3.  Animals were anesthetised with ketamine/xylazine (1mg/kg/0.1mg/kg ip).  Blood, for 
immunoassay, was collected via cardiac puncture and stored on ice.  Animals were 
perfused with 0.9% saline solution and subsequently with ~250ml of 4% PFA (w/v) 
in 0.1M PB.  Brains were post-fixed for three hours and washed three times in PBS.  
Brains were sectioned using a 0.1mm brain matrix and further cut using a vibratome 
(Leica, Australia) at 40µm thick sections.  Tissue sections were serially assigned to 
conditions in the following order: Controls; GR sections; MR sections.  The controls 
were processed as described in Chapter 3.  Immunohistochemistry for GR and MR 
sections were processed in parallel. 
Imaging.  Sections were imaged using an Olympus FV1200 Confocal Microscope 
equipped with 405nm, 473nm and 559nm solid state lasers.  First, a mosaic image of 
the amygdala was created using the “Multi Area Time Lapse” function in the 
Olympus Fluoview software (Olympus), to ensure accurate sampling.  The mosaic 
was imaged on one z-plane, using 473nm and 559nm lasers, with a 20× (0.86 NA) oil 
objective.  From the mosaic image, six ROI were selected to be imaged using the 60× 
(1.35 NA) oil objective with a 2.5× sensor zoom.  Two ROIs were selected from the 
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LA, two from the CeA, and two from the BA (operationalised in Chapter 3).  The 
start and end points were individually set for each ROI, and added to the “Registered 
Point List” and subsequently scanned.  Each image was acquired using a 1024×1024 
scan format, and contained 65 z-stacks, with a step size of 0.3µm.  The maximum 
optical resolution of each image was 83.97µm × 83.97µm with a z-depth of 19.5µm. 
Deconvolution.  Images were deconvolved using Hyugen’s Professional software 
(Scientific Volume Imaging), in order to improve the SNR, and restore the resolution 
along the z-axis by removing signals that were not present in at least two stacks 
(Bolte & Cordelières, 2006).  The deconvolution parameters were set at a maximum 
of 20 iterations and a quality threshold of 0.01.  For DAPI-labelling, the SNR was set 
at 10, and for puncta labelling (i.e. receptor- and PSD-95-labelling), the SNR was set 
at 5. 
3D reconstruction and colocalisation in Imaris.  Images were further 
processed in Imaris (Version 8.2, Bitplane).  Firstly, images were imported into 
Arena View and then individually cropped along the z-axis to remove any artefacts 
and blebs at the top and/or bottom of sections.  Subsequently, a random image was 
selected to establish the parameters for batch processing.  First the parameters for 
nuclei surfaces were established.  DAPI labelling was reconstructed as a “surface 
object” layer.  Parameters for the surface object layer were as follows: smoothing 
and background subtraction were enabled with a threshold of 1.5m; the maximum 
diameter of the largest sphere was set at 15m; and the interactive histogram 
threshold minima was set at 2.42 arbitrary units for GR sections, and 1.00 arbitrary 
units for MR sections.  These parameters were saved and applied to all images. 
The surface object layer was subsequently used to create three new mask 
channels: GR or MR labelling within nuclei; GR or MR labelling outside of nuclei; 
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and PSD-95 labelling outside of nuclei.  The effect of mask channels and the 
resultant labelling was described in more detail in the Results section.  For each of 
the masked channels, we digitally reconstructed the immunoreactive labelling into 
“spot objects”.  Using a random image, receptor labelling inside of surfaces was 
reconstructed into 3D spot objects with the following parameters: the minimum 
diameter for both genomic GR and MR spots was set at 0.2m; the interactive 
histogram was filtered on quality where GR spots had a threshold minima of 7.996 
arbitrary units and MR spots had a threshold minima of 4.638 arbitrary units.  Extra-
nuclear GR and MR spots were created from the mask channel containing receptor-
like labelling outside of surfaces.  The minimum diameter for extra-nuclear receptor 
spots was also set at 0.2m.  The interactive histogram was used to filter spots based 
on quality; for GR, the minima was set at 2.789 arbitrary units, while MR was set at 
3.456 arbitrary units.  PSD-95 spots were reconstructed from the mask channel 
containing PSD-95 labelling outside of nuclei surfaces.  PSD-95 spots had a 
minimum estimated diameter of 0.35m, with background subtraction enabled.  The 
interactive histogram threshold for PSD-95 spots was filtered by quality; in GR 
sections the minima was set at 2.797 arbitrary units and in MR sections the minima 
was set at 3.769 arbitrary units.  Once these parameters were finalised, they were 
applied to the batch to maintain consistency between images. 
Colocalisation analysis was performed using the nearest-neighbour distance 
approach (Bolte & Cordelières, 2006; Lagache et al., 2015), described in detail in 
Chapter 3.  In Imaris, the “spot colocalisation” ImarisXT plugin was used to create 
new spot objects.  Extra-nuclear GR or MR spots that were within 0.1m of PSD-95 
spots were classified as colocalised.  Two layers of colocalised spot objects were 
created: the number receptor spots within 0.1m of PSD-95 spots; and the number of 
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PSD-95 spots within 0.1m of receptor spots.  An online supplementary video is 
provided in Appendix E, which demonstrates the process of 3D reconstruction and 
the three-dimensional nature of the surface and spot objects. 
Design 
In line with object-based analysis (Lagache et al., 2015), we were able to quantify the 
number of spot objects for analysis.  As stated above, colocalised spots referred to 
the number of PSD-95 spots within 0.1µm of GR or MR spots outside of DAPI 
nuclei surfaces.  We referred to the spots located inside of DAPI surfaces as: 
genomic GR spots and genomic MR spots.  The density of genomic spots was 
calculated: per nuclei volume, or per total volume; most comparisons were made 
based on the spot density, per total volume.  The number of genomic GR and MR 
spots, however, was compared between amygdala subregions, based on the density 
per nuclei volume.  This was calculated by diving the number of spots by the volume 
within DAPI surfaces; which accounted for any differences in nuclei volume 
between amygdala subregions.   
All statistical analysis was performed in SPSS, where statistically significant results 
were accepted as p < .05. 
Results 
Controls 
Immunoreactive labelling in control sections were similar in presentation to 
the fluorescent and reagent controls used in protocol validation (Chapter 4).  This 
suggested that the labelling seen was specific. 
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Mosaic Images 
Mosaic images were taken for each section in order to ensure accurate 
sampling of amygdala subnuclei.  Mosaic images were captured at 20× (0.86 NA) 
magnification using 473nm (green) and 559nm (red) lasers.  Coordinates, for the 
images used for 3D reconstruction and colocalisation analysis, were plotted on the 
mosaic image (white dots in Figure 20).  Two images from each subnuclei (three 
subnuclei: LA, CeA and BA) were sampled from each section. 
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Figure 20.  Mosaic image of rat brain tissue, taken at 20× (0.86 NA) oil objective.  
White dots depict the coordinates of images sampled for analysis.  Overlay in white 
displays the boundaries of the different subregions of the amygdala. 
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Deconvolution of Images 
Images were deconvolved using Huygens Professional (Scientific Volume 
Imaging).  Deconvolution parameters were differentially set for each channel.  For 
DAPI-labelling, the SNR was set at 10, to prevent light scattering. The quality 
threshold was set at 0.01 with a maximum of 20 iterations.  For PSD-95-labelling, 
SNR was set at 5, with a quality threshold of 0.01 and a maximum of 20 iterations.  
These parameters were held constant for all sections.  After deconvolution, the 
appearance of light scattering in both blue and red channels was greatly reduced, 
(Figure 21) and the labelling relative to the background was more distinct.  For PSD-
95 labelling, the size of PSD-95 puncta was reduced (Figure 21c and Figure 21d). 
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Figure 21.  Maximum intensity projections for DAPI and PSD-95 are depicted, before 
and after deconvolution.  The images depicted contained 52 stacks, with a thickness 
of 15.6µm.  Deconvolved images b) and d) show reduced light scattering. 
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GR- and MR-like labelling was also deconvolved using Huygens 
Professional.  We found that using conservative parameters removed an excessive 
amount of pixel values.  Due to the small size of GR- and MR-puncta, the 
conservative parameters treated some faint labelling as background, and 
subsequently removed smaller puncta; resulting in an underestimation of receptor 
density.  To avoid over correction, less conservative parameters were used.  This 
resulted in a higher SNR without excessive removal of pixel values, but it did not 
completely resolve out-of-focus light.  Labelling that was not present for two or more 
stacks were removed, suggesting that only real puncta labelling was preserved (Bolte 
& Cordelières, 2006).  Deconvolution improved the SNR (Figure 22) resulting in 
more well defined puncta.  In addition, deconvolution improved shape of the puncta 
along the x, y and z-axes (Figure 22).  Puncta were more distinct and there was less 
smearing of objects along the z-plane (Figure 22c and 22d depict GR puncta, and 
Figure 22g and 22f depict MR puncta. 
MR-like labelling in raw images displayed less homogenous labelling 
compared to the labelling seen during protocol validation (Chapter 4).  Moreover, 
deconvolution also improved the SNR and distinctiveness for both nuclear (and 
extra-nuclear) puncta (Figure 22f and 22h).  This rendered MR sections suitable for 
3D reconstruction and object-based colocalisation (Fogarty et al., 2013).  
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Figure 22.  Maximal z-projections are displayed for GR and MR labelling before and 
after deconvolution.  Z-thickness of deconvolved images for GR and MR show the 
correction for noise, and the change in the size of puncta: changes in GR puncta can 
be seen in c) and d); changes in MR puncta can be seen in g) and h). 
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Nuclear Surfaces 
DAPI-labelling was used to create nuclei surfaces.  To create an unbroken 
surface, smoothing was enabled at a threshold of 1.5m and background subtraction 
thresholding was enabled.  The diameter of largest sphere was set at 15m, based on 
the maximum diameter of neuronal nuclei in previous literature (Chareyron, 
Lavenex, Amaral, & Lavenex, 2011).  Using the interactive histogram, a minimum 
threshold was used to correct for any artefacts and blebs (Fogarty et al., 2013), with 
arbitrary units of 2.42 for GR-sections, and 1.00 for MR-sections (Figure 23). 
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Figure 23.  Creation of nuclear surfaces for GR and MR sections.  First row of images 
a) and d) display unfiltered fluorescence.  Second row of images b) and e) display 
filtered DAPI labelling.  Third row c) and f) displays Imaris-generated 3D surfaces.  
Scale bar: 10µm 
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Creation of Genomic GR and MR 
The presentation of puncta labelling was characterised during protocol 
validation (Chapter 4), and found to meet the criterion for spot creation (Fogarty et 
al., 2013).  After the reconstruction of nuclei surfaces, we demarcated between intra- 
and extra-nuclear labelling.  Using the DAPI-surfaces, we filtered the intra-nuclear 
fluorescent labelling of genomic GR- or MR-like structures.  We selected the DAPI 
surface objects layer and used the “mask all” function under the edit tab.  As we 
wanted to mask for receptor-like labelling inside surfaces, we selected the GR (or 
MR) channel and set “voxels outside of surface” to 0.0.  We also enabled “duplicate 
channel before applying mask”, in order to preserve the original channel.  
Consequently, a new source channel was created for GR-like labelling or MR-like 
labelling inside of DAPI-surfaces (Figure 24b and figure 24e). 
Next, 3D genomic GR or MR spot objects were reconstructed from the 
filtered fluorescence.  We selected the new source channel, which contained the 
filtered receptor-labelling, used it to add a spot objects layer.  Background 
subtraction was enabled, and GR- and MR-labelling was determined to have an 
estimated diameter of 0.2m, based on previous literature (van Steensel et al., 1996).  
We used the histogram threshold in order to detect as many spots as possible without 
creating artificial objects; around the point of inflection on the histogram (Fogarty et 
al., 2013).  For GR-like labelling, spots were filtered on quality, with a threshold 
minima of 7.996 arbitrary units (Figure 24c).  For MR-like labelling, spots were also 
filtered on quality, with a threshold minima of 4.638 arbitrary units (Figure 24f).  
Genomic GR- and genomic MR-spots generated from GR- and MR-like labelling 
could subsequently be used for analysis (link to online supplementary video in 
Appendix E). 
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Figure 24.  Intra-nuclear GR- and MR-like labelling was filtered based on nuclei 
surfaces.  The first row a) and d) displays unfiltered labelling.  The second row b) 
and e) displays the filtered labelling.  The third row c) and f) displays detected 
labelling that was reconstructed as spots.  Scale bar: 10µm 
 94 Chapter 5: Corticosteroid Receptor Densities in the Amygdala 
Creation of Extra-nuclear GR and MR and Post-synaptic Terminals 
Spot objects were also created for GR- and MR-like structures outside of 
DAPI-surfaces.  We selected the surface objects layer and used it to filter receptor-
like labelling outside of nuclei surfaces.  Again, we used the “mask all” option under 
the edit tab, and selected the original channel containing the unfiltered GR or MR 
fluorescence.  However, to filter the fluorescence outside of nuclei surfaces, we set 
“voxels inside of surfaces” (as opposed to voxels outside of surfaces) to 0.0.  This 
mask channel was also created as a duplicate channel in order to preserve the original 
data (Figure 25). 
Extra-nuclear GR and MR spots were constructed from the filtered 
fluorescence.  Firstly, we selected the new channel created, which contained the 
filtered extra-nuclear labelling, to create a new spots objects layer.  For both GR- and 
MR-like labelling, background subtraction was enabled, and extra-nuclear spots had 
an estimated diameter of 0.2m, maintaining consistency with the diameter of 
genomic spots.  For GR-like labelling, the histogram threshold was used to filter 
spots with quality above 2.789 arbitrary units.  For MR-like labelling the histogram 
threshold was set to filter spots with quality above 3.456 arbitrary units (Figure 25c 
and Figure 25f). 
PSD-95-like labelling was also filtered using the DAPI-surfaces.  Using the 
DAPI-surfaces “mask all” option, the PSD-95 channel was selected, and the “voxels 
inside of surfaces” were set to 0.0.  This mask was also created as a duplicate 
channel, in order to preserve the original PSD-95 labelling (Figure 25).  Spot objects 
were created from the filtered PSD-95 layer, with an estimated diameter of 0.35m 
(background subtraction enabled) based on the PSD-95 labelled spines measured in 
previous studies (Cooke & Woolley, 2005; Fogarty et al., 2013).  The histogram 
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threshold for PSD-95 spots in GR sections were filtered by quality with a minima of 
2.797 arbitrary units.  PSD-95 spots in MR sections had a minima of 3.769 arbitrary 
units (Figure 25). 
 
Figure 25.  Creation of extra-nuclear spots for GR-like labelling and MR-like labelling 
and PSD-95.  Fluorescence labelling before and after filtering is also shown.  Scale 
bar: 10µm 
Colocalisation of Corticosteroid Receptors at Post-synaptic Terminals 
Object-based colocalisation analysis was performed using Imaris.  
Colocalised spots were calculated using the nearest-neighbour distance approach 
 96 Chapter 5: Corticosteroid Receptor Densities in the Amygdala 
(Bolte & Cordelières, 2006), described in Chapter 3.  We used the ImarisXT plugin, 
“spot colocalisation”, to create a new layer of colocated spots (Figure 26, and online 
supplementary video 2, linked in Appendix E).  As we were interested in an overlap 
between receptor spots with PSD-95 spots, colocated spots were created by selecting 
the extra-nuclear receptor spot layer and the PSD-95 spot layer, from the menu.  We 
chose a distance threshold for analysis that ensured that at least half of the smallest 
object would be covered (Lachmanovich et al., 2003).  As the smallest object was the 
receptor spot, which had an estimated diameter of 0.2µm, the maximum distance 
threshold was set at 0.1µm.  Using Imaris, two new sets of collocated objects were 
created: the first set contained the number of extra-nuclear receptor spots that were 
within 0.1 µm from PSD-95 spots; and the second set contained the number of PSD-
95 spots within 0.1µm from extra-nuclear receptor spots.  There were no differences 
in the number of colocalised objects between the two sets. 
We also observed some yellow fluorescence (suggesting a colocalised signal; 
indicated by the asterisk in Figure 26c), that was not reconstructed as a colocalised 
object (Figure 26c and Figure 26f).  This further supports the importance of the 
added z-resolution used in object-based analysis (Lagache et al., 2015).  Moreover, in 
some images, we also observed overlapping spot objects that were not recreated as 
colocated spots as they exceeded the maximum distance threshold.  This 
demonstrates the consistency of the criterion used, as these overlaps could have been 
misattributed as colocalised objects during manual counting (Bolte & Cordelières, 
2006). 
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Figure 26.  Creation of colocalised spot objects from overlaps between 
corticosteroid receptors and PSD-95 (indicated by white arrows).  Asterisk indicates 
seemingly colocalised fluorescence that was not labelled in 3D reconstruction.  
Scale bar: 3µm 
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Corticosterone levels 
Corticosterone levels were measured using a competitive binding ELISA 
(Table 3).  Rat 1 weighed 255g and had a corticosterone level of 18.61ng/ml.  Rat 2 
weighed 250g and had corticosterone level of 29.55ng/ml.  Rat 3 weighed 260g and 
had corticosterone level of 68.62ng/ml.  The corticosterone levels of Rats 1 and 2 
were similar to previous literature of rats familiar to handling (Deutsch-Feldman et 
al., 2015).  Rat 3 had higher levels of corticosterone, similar to that of rats that were 
not familiar with handling procedures (Deutsch-Feldman et al., 2015).  
Corticosterone levels were below that of rats previously reported as “stressed”, 
which typically have plasma corticosterone levels around 250ng/ml (Dhabhar, 
McEwen, & Spencer, 1993). 
Table 3 
Rat Plasma Corticosterone Levels were lower than that of Stressed Rats 
 Weight (g) Plasma Corticosterone (ng/ml) 
Stressed Rata 200 to 300 200 
Rat 1 255 18.61 
Rat 2 250 29.55 
Rat 3 260 68.62 
aAverage corticosterone level of “stressed rat” were adapted from "Stress response, adrenal steroid 
receptor levels and corticosteroid-binding globulin levels - a comparison between Sprague-Dawley, 
Fischer 344 and Lewis rats," by F. S. Dhabhar, B. S. McEwen and R. L. Spencer, 1993, Brain Research, 
616, p. 91. 
Analysis 
Descriptive Statistics 
A total of 155 images were analysed.  There was a total of 81 images for GR 
sections (nrats = 3), and 74 images for MR sections (nrats = 2).  To compare between 
images, spots were adjusted based on their volumetric density.  The number of spots 
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for each image was divided by its total volume and multiplied by 1000 and the 
volumetric density was displayed as spots per 1000m3 (or 103m3). 
The variability between rats, of the volumetric densities of genomic and 
colocalised GR and MR, are reported in Tables 4 to 6.  Rat 1 had the lowest amount 
of plasma corticosterone (18.63 ng/ml).  The highest mean density of genomic GR, 
spots per 1000m3, was in the CeA (M = 52.71, SD = 25.34), and the highest density 
of colocalised GR spots was in the LA (M = 3.22, SD = 1.88).  Skewness and 
kurtosis suggested that the volumetric density was more normally distributed for 
colocalised GR spots compared to genomic GR spots (Table 4). 
Rat 2 showed the highest levels of genomic GR (M = 62.82, SD = 19.77) and 
genomic MR (M = 42.09, SD = 21.97) in the CeA.  In rat 2, genomic GR spots had 
the lowest mean density in the BA (M = 19.39, SD = 8.82), whereas genomic MR 
spots had the lowest mean density in the LA (M = 14.68, SD = 8.46).  For both 
colocalised GR and MR spots, the lowest mean density was within the LA, where the 
mean densities per 1000m3 (standard deviation in parentheses) were = 3.10 (0.87) 
and = 1.70 (0.64) respectively.  Distribution densities of colocalised GR receptors 
were skewed slightly towards the right (more images with a volumetric density 
above the mean), whereas colocalised MR receptors were skewed slightly towards 
the left (more images with a volumetric density below the mean; displayed in Table 
5). 
Rat 3 had the highest amount of blood corticosterone (68.82ng/ml), more than 
two times as high as Rat 2 (29.55 ng/ml).  Unlike rat 2, rat 3 had a higher mean 
density of genomic MR spots (M = 39.19, SD = 32.26) compared to genomic GR 
spots (M = 14.40, SD = 9.62) per 1000m3.  Similar to rat 1 and rat 2, rat 3 had the 
highest density of genomic GR spots in the CeA (M = 24.48, SD = 9.89).  Skewness 
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and kurtosis for the densities of genomic GR and MR spots were also higher 
compared to rat 2, indicating that the volumetric density of images, sampled from rat 
3 were less normally distributed.  The highest density of colocalised GR spots in rat 
3, was found in the CeA (M = 3.68, SD = 0.79), however, the highest density of 
colocalised MR spots were found in the BA (M = 2.57, SD = 1.01), which can be 
seen in Table 6.
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Table 4 
Descriptive statistics for Rat 1: The distribution density of GR-like spots per 1000µm3 
 Rat 1a 
  Genomic Colocalised 
 Nimages M (SD) Range Skewness Kurtosis M (SD) Range Skewness Kurtosis 
Glucocorticoid 
Receptorb 
12 38.06 (24.67) 76.99 1.22 0.63 2.84 (1.14) 3.74 0.89 0.16 
LA 4 42.96 (27.11) 59.91 1.08 0.11 3.22 (1.88) 3.74 0.15 -5.07 
CeA 4 52.71 (25.34) 57.96 1.62 3.04 2.62 (0.76) 1.60 0.76 -1.77 
BA 4 18.50 (5.11) 11.27 -0.24 -2.86 2.67 (0.60) 1.46 -0.68 1.70 
a corticosterone level = 18.63 ng/ml, bn(sections) = 2 
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Table 5 
Descriptive statistics for Rat 2: The distribution density of GR-like spots and MR-like spots per 1000µm3 
 Rat 2a 
  Genomic Colocalised 
 Nimages M (SD) Range Skewness Kurtosis M (SD) Range Skewness Kurtosis 
Glucocorticoid 
Receptorb 
40 38.04 (24.21) 91.39 0.80 -0.22 3.38 (1.07) 3.90 -0.31 -0.81 
LA 13 33.36 (18.29) 66.88 1.04 -0.58 3.10 (0.87) 2.43 1.59 -1.23 
CeA 13 62.82 (19.77) 62.10 0.17 -0.67 3.76 (1.08) 3.63 -0.70 -0.52 
BA 14 19.39 (8.82) 27.06 0.80 -0.22 3.30 (1.20) 3.90 -0.31 -0.81 
Mineralocorticoid 
Receptorc 
34 23.84 (18.98) 62.75 1.00 -0.08 1.72 (0.70) 3.08 0.67 0.28 
LA 11 14.68 (8.46) 24.96 0.24 -1.15 1.70 (0.64) 1.81 0.39 -1.24 
CeA 11 42.09 (21.97) 62.07 -0.72 -0.93 1.86 (0.79) 2.65 1.10 1.16 
BA 12 15.51 (9.17) 26.23 -0.04 -1.33 1.61 (0.71) 2.51 0.41 0.27 
acorticosterone level = 29.55 ng/ml, bn(sections) = 7, cn(sections) = 7 
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Table 6 
Descriptive statistics for Rat 3: The distribution density of GR-like spots and MR-like spots per 1000µm3 
 Rat 3a 
  Genomic Colocalised 
 Nimages M (SD) Range Skewness Kurtosis M (SD) Range Skewness Kurtosis 
Glucocorticoid 
Receptorb 
29 14.40 (9.62) 40.55 1.35 1.99 3.08 (0.91) 3.81 0.47 -0.16 
LA 10 10.65 (5.35) 14.91 0.57 -1.18 3.03 (0.89) 2.40 0.88 -0.59 
CeA 9 24.48 (9.89) 31.56 0.89 0.48 3.68 (0.79) 2.56 0.85 0.75 
BA 10 9.07 (4.85) 14.35 0.79 -0.13 2.60 (0.77) 2.61 0.32 0.03 
Mineralocorticoid 
Receptorc 
40 39.19 (32.26) 135.77 1.63 2.55 2.23 (0.78) 3.04 0.55 -0.23 
LA 13 24.10 (19.22) 58.95 0.98 -0.05 2.08 (0.46) 1.42 0.77 -0.63 
CeA 14 58.47 (39.03) 115.74 1.28 0.22 2.07 (0.71) 2.67 0.21 0.30 
BA 13 33.52 (25.44) 91.18 1.43 2.33 2.57 (1.01) 2.78 -0.03 -1.48 
acorticosterone level = 68.82ng/ml, bn(sections) = 6, bn(sections) = 7  
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Genomic Corticosteroid Receptors vs. Corticosteroid Receptors at Post-
Synaptic Terminals 
The densities of genomic and colocalised GR and MR from rats 2 and 3 were 
pooled into section means (nsections = 13).  Two paired samples t tests were performed 
as part of preliminary analysis (Figure 27).  The first paired samples t test was 
performed on the densities of colocalised GR spots and colocalised MR spots.  A 
statistical difference was found t(12) = 4.74, p < .001, 95% CI [0.62, 1.97] between 
the densities of colocalised GR and MR, where colocalised GR (M = 3.19, SD = 
0.85) had a significantly higher density than colocalised MR (M = 2.04, SD = 0.52).  
The second paired samples t test was performed between the densities of genomic 
GR spots and genomic MR spots.  No significant difference was found between the 
densities of genomic GR spots (M = 26.77, SD = 16.27), and genomic MR spots (M 
= 27.89, SD = 14.10), t(12) = -0.18, p = .858. 
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Figure 27. Mean densities of genomic and colocalised GR and MR spots.  Symbols 
represent section averages.  Error bars display ±1 Standard Error of the Mean 
(SEM). 
Genomic GR spot density was compared between amygdala subregions.  The 
number of genomic GR spots were adjusted by the volume of DAPI-surfaces and 
multiplied by 1000 (genomic spots per 1000m3 of DAPI).  For each section, the 
mean density for each amygdala subregion was calculated (nrats = 3).  A repeated 
measures, one-way analysis of variance (ANOVA) was performed on the amygdala 
subregions (LA vs. CeA vs. BA) from 12 sections.  The CeA had the highest density 
of genomic GR (M = 256.21, SD = 89.61), followed by the LA (M = 159.45, SD = 
87.19), and finally the BA (M = 127.15, SD = 59.09).  Mauchley’s test of sphericity 
was not violated (p = .721) and sphericity was assumed.  A significant difference was 
found between amygdala subregions, F(2, 22) = 21.88, p < .001, partial η2 = .665.  
Pairwise comparisons (Bonferroni adjustment) revealed that the CeA had a 
significantly higher density of genomic GR spots compared to the LA (p = .004), and 
the BA (p < .001). 
We conducted some preliminary analyses to see if there was a difference in 
genomic MR spot density between amygdala subregions (nrats = 2).  Density of MR 
spots was also represented as spots per 1000m3 of DAPI, and the densities for each 
subregion were averaged for each section (nsection = 13).  Missing values resulted in 
the attrition of one section.  A one-way repeated measures ANOVA was performed 
on amygdala subregions (LA vs. CeA vs. BA), where the CeA had the highest 
density of genomic MR spots (M = 272.61, SD = 139.61) followed by the BA (M = 
195.25, SD = 119.70), and the LA (M = 129.49, SD = 68.35).  Assumption of 
sphericity was met (p = .206), and a significant difference was found F(2, 24) = 8.55, 
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p = .002, partial η2 = .416.  Pairwise comparisons (Bonferonni adjustment) showed a 
significant difference between the densities in the CeA and LA subregions (p = .001).  
The mean densities for genomic GR and MR spots are depicted in Figure 28. 
 
Figure 28. Mean density of receptor spots located within DAPI surfaces, adjusted by 
the surface volume.  Light grey bars represent density of GR spots, per amygdala 
subregion.  Dark grey bars represent density of MR spots, per amygdala subregion.  
Error bars represent ±1 SEM. 
Proportion of Synapses that contain Corticosteroid Receptors 
Next, we calculated the volumetric density of PSD-95 spots in GR and MR 
sections (dark bars in Figure 29).  In GR sections (nrats = 3), PSD-95 had a mean 
density (standard deviation in parentheses) of 34.45 (10.39) spots per 1000m3.  The 
mean density of PSD-95 spots was higher in MR sections (nrats = 2), with a mean 
density of 40.97 (18.35) spots per 1000m3. 
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The proportion of post-synaptic sites containing corticosteroid receptors, per 
1000m3, was calculated by dividing the number of colocalised spots by the number 
of PSD-95 spots (Bolte & Cordelières, 2006).  When multiplied by 100, this 
provided an indication of the percentage of PSD-95 spots that contained GR or MR 
spots.  GR sections had a higher percentage of PSD-95 spots that contained GR spots 
was 9.28% (2.86), compared with MR sections where the number of PSD-95 spots 
that contained MR was 5.27% (2.17). 
 
Figure 29.  Amount of PSD-95 spots that contain colocalised GR or MR spots.  The 
mean volumetric density of PSD-95 spots for GR or MR sections is indicated by the 
black bars.  The mean volumetric density of colocalised GR or MR spots is indicated 
by light bars. 
A preliminary analysis was performed in order to see if there was any 
difference between amygdala subregions.  Two, one-way repeated measures 
ANOVAs were performed: one for GR sections; and one for MR sections.  For each 
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section, the average proportion was calculated for each amygdala subregion, and 
subregions were compared within sections. 
For GR sections, analysis was performed on 12 sections (nrats = 3), with an 
attrition of three sections due to missing values.  A one-way repeated measures 
ANOVA conducted on amygdala subregions (LA vs. CeA vs. BA).  The CeA had the 
highest degree of colocalisation (M = 11.75, SD = 3.33), followed by the LA (M = 
8.88, SD = 1.87), and then the BA (M = 8.46, SD = 1.91); displayed in Figure 30.  
Mauchly’s test of sphericity was not violated, p = .106, and sphericity was assumed.  
The ANOVA revealed a significant difference between brain regions, F(2, 24) = 
11.12, p < .001, partial η2 = .503.  Pairwise comparisons (Bonferroni adjustment) 
showed that the mean proportion of PSD-95 spots that contain GR spots was 
significantly higher in the CeA compared to the LA (p = .006), and in the CeA 
compared to the BA (p = .016). 
 
Figure 30. Bar graph depicting the proportion of extra-nuclear GR spots that were 
colocalised with PSD-95 spots, within each brain region.  Error bars represent ±1 
SEM. 
For MR sections, a one-way repeated measures ANOVA was also conducted 
on amygdala subregions (LA vs. CeA vs. BA) to determine the proportion of PSD-95 
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spots that were colocalised with MR-spots.  Analysis was performed on 13 sections 
(nrats = 2), after missing values lead to the attrition of one section.  Descriptive 
statistics showed that the CeA had the highest degree of colocalisation (M = 5.62, SD 
= 2.33), followed by the BA (M = 5.17, SD = 1.50), and finally the LA (M = 4.70, SD 
= 2.16); displayed in Figure 31.  One-way repeated measures ANOVA was 
performed on amygdala subregions (LA vs. CeA vs. BA) to see if there was a 
difference in the number of PSD-95 spots that were colocalised with MR spots.  
Assumption of sphericity was not violated (p = .717).  There were no significant 
differences found in proportion of PSD-95 spots containing MR spots, between 
amygdala subnuclei, F(2, 26) = 1.72, p = .199. 
 
Figure 31. Bar graph depicting the proportion of extra-nuclear GR spots that were 
colocalised with PSD-95 spots, within each brain region.  Error bars represent ±1 
SEM. 
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Chapter 6:  Discussion 
The dual system of GR and MR have also been shown to have two further 
subpopulations that have different temporal domains; fast and slow (Joels et al., 
2013).  Fast corticosteroid receptors have been located at the membrane of synapses, 
whereas slow corticosteroid receptors are located within the cytoplasm and nuclei of 
neurons (Prager & Johnson, 2009).  It is currently unknown whether there is a 
structural difference between the two subpopulation of corticosteroid receptors 
(Prager & Johnson, 2009).  As such, there are fewer methods available to delineate 
the subpopulations of these receptors; limiting the available data (Groeneweg, 2014).  
Previous studies have used electron microscopy (L. R. Johnson et al., 2005; 
Komatsuzaki et al., 2012; Prager et al., 2010) or cell fractionation (Moutsatsou et al., 
2001) to quantify these subpopulations, however the data around the distribution of 
membrane-associated corticosteroid receptors is still emerging.  In this study, we 
used confocal imaging and colocalisation analysis to characterise the subpopulations 
of GR and MR, as confocal imaging has a larger field of view than electron 
microscopy (Bacallao et al., 1995), and better spatial resolution than fractionation 
assays (Ahima & Harlan, 1990). 
Recent advances in technology have introduced more accurate and reliable 
colocalisation techniques (Zinchuk & Grossenbacher-Zinchuk, 2009).  One such 
technique, developed by Fogarty et al. (2013), used 3D reconstruction in Imaris 
(Bitplane) for more accurate object-based colocalisation analysis.  In this study we 
aimed to test the feasibility of adapting Fogarty’s approach of 3D reconstruction to 
quantifying corticosteroid receptors at the excitatory post-synaptic sites.  Following 
this, we aimed to use the data obtained from 3D reconstruction to perform some 
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initial analyses on the distribution densities of GR and MR.  The first part of this 
chapter discusses the feasibility of using Fogarty’s approach for characterising the 
distribution of GR and MR.  The second part of this chapter describes the findings, 
and discusses how Fogarty’s approach can be further applied to future stress 
research. 
Applicability of 3D Reconstruction for Characterising Corticosteroid Receptors 
GR and MR labelling can be Reconstructed as Spots 
In Chapter 5, we aimed to test the feasibility of adapting Fogarty’s approach, 
in order to delineate between populations of genomic corticosteroid receptors and 
membrane-associated corticosteroid receptors at synapses.  Fogarty et al. (2013) 
utilised the commercially available software Imaris (Bitplane), in order to three-
dimensionally reconstruct neuronal surfaces and pre- and post-synaptic terminals.  In 
order to adapt Fogarty’s approach of spot reconstruction to corticosteroid receptors, 
the labelling of GR, MR, and PSD-95, needed to present as: a) well-defined spots; 
and b) easily distinguishable from background fluorescence (Fogarty et al., 2013).  In 
our study, we found that PSD-95 labelling was similar to that of previous research 
(Fogarty et al., 2013; Soria Van Hoeve & Borst, 2010), and presented as distinct 
puncta scattered throughout the sections.  We also found that GR- and MR-like 
labelling was spot-like; which was consistent with the fluorescent labelling seen in 
previous confocal imaging studies (Sarabdjitsingh et al., 2010; van Steensel et al., 
1996), but not as distinct as PSD-95 labelling. 
Using Huygen’s deconvolution software (Scientific Volume Imaging), we 
found that the amount of background fluorescence was reduced and the SNR was 
improved.  Moreover, we found that after deconvolution, the distinctiveness of GR- 
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and MR-like structures was increased, and were more suitable for 3D reconstruction.  
Deconvolution was not only used to increase the resolution of the images; previous 
research has shown that deconvolution has been used to restore images to more 
closely resemble the original object (Dodt et al., 2007).  Consequently, deconvolved 
images are less likely to result in false positives, thus improving the overall accuracy 
of colocalisation analysis (Zinchuk & Grossenbacher-Zinchuk, 2009). 
Subsequent to performing deconvolution, we were able to reconstruct GR, 
MR and PSD-95 structures as spot objects, and perform colocalisation using the 
nearest neighbour approach for object-based colocalisation (Lagache et al., 2015).  
Object-based methods of colocalisation have been shown to be more accurate and 
statistically robust compared to traditional pixel based methods (Lagache et al., 
2015).  While pixel based methods are widely used (Dunn et al., 2011), they have 
reduced resolution compared to object-based methods, and the reduced resolution 
increases the likelihood of false positives (Bolte & Cordelières, 2006; Lagache et al., 
2015).  Alternatively, object-based methods plot the spatial coordinates of labelled 
structures within an image.  As such, object-based methods have added resolution 
along the z-axis improving the overall accuracy of quantification (Lagache et al., 
2015).  Much of the literature reviewed used pixel-based methods of colocalisation 
(Han et al., 2014; L. R. Johnson et al., 2005; Kil & Kalinec, 2013; van Steensel et al., 
1996), and this is the first study that uses object-based colocalisation analysis to 
investigate the distribution of GR and MR at post-synaptic sites in the amygdala. 
While this study used object-based analysis to characterise the colocalisation 
of GR and MR at excitatory post-synaptic terminals, this approach could be adapted 
to characterising GR and MR within other types of synapses.  For example, GR and 
MR have also been located within the membrane at pre-synaptic sites (Komatsuzaki 
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et al., 2012; Prager et al., 2010).  By using a marker for pre-synaptic component (e.g. 
anti-VGLUT2; Fogarty et al., 2013), this method could be used to characterise GR 
and MR that are located at pre-synaptic sites.  Moreover, the semi-automated nature 
of this approach allows for increased throughput, and the use of computer algorithms 
standardises image treatment (Zinchuk & Grossenbacher-Zinchuk, 2009), and 
provides more consistent quantification (Lagache et al., 2015). 
The reconstruction of spots for colocalisation, however, is dependent on 
consistent spot-like labelling of GR and MR.  In previous literature, GR and MR 
labelling does not always present as puncta.  For example, GR and MR labelling in 
amygdala neurons have been shown to have increased cytoplasmic distribution after 
stress (Han et al., 2014), and labelling appeared more homogenously diffused in the 
cytoplasm and nucleus.  Moreover, hippocampal cells have also been shown to have 
a higher density of GR and MR compared the amygdala (Ahima et al., 1991; Caudal 
et al., 2014; Marlier et al., 1997; Morimoto et al., 1996).  As such, GR and MR 
labelling in hippocampal neurons appear more homogenous and are less likely to 
present as well defined spots (Sarabdjitsingh et al., 2010).  In such situations, it 
would be difficult to use Imaris 3D reconstruction to quantify genomic GR and MR, 
limiting 3D reconstruction to membrane-associated populations.  However, 
homogenous labelling may also have been due to the choice of antibodies 
(Sarabdjitsingh et al., 2010) or the absence of light-scattering correction (Bolte & 
Cordelières, 2006; van Steensel et al., 1996).  As a result, we strongly suggest that 
future studies adapting this method firstly characterise the labelling of the antibodies 
used, and subsequently employ reliable deconvolution techniques prior to 
colocalisation analysis. 
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Nuclei can be reconstructed as Surfaces to identify gGR and gMR populations 
In their original method, Fogarty and colleagues (2013) originally created 
neuronal surfaces, which we adapted, to create nuclei surfaces.  We used DAPI to 
stain the nuclei within the amygdala, and subsequently reconstructed the DAPI-
labelling as surface objects.  This allowed us to demarcate between the populations 
of intra-nuclear corticosteroid receptors from extra-nuclear corticosteroid receptor 
populations.  Additionally, the nuclei surfaces allowed us to quantify the amount of 
genomic corticosteroid receptor spots, and subsequently compare its distribution 
density with corticosteroid receptors spots located at excitatory-post-synaptic 
terminals (Figure 32). 
 
Figure 32. Image of genomic and colcocalised GR and MR spots after 3D 
reconstruction in Imaris.  Scale bar: 5µm 
In this study, however, we did not distinguish between the types of nuclei we 
were labelling.  As glial cells have also been found to contain GR and MR (Matsusue 
et al., 2014), it was possible that we were also quantifying genomic GR and MR 
within glia.  Future studies can control for this by using fluorescent markers specific 
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to neurons, and additionally recreate neuronal membrane surfaces.  Alternatively, 
researchers could also adapt this approach to study the populations of GR and MR 
within various glial cells as GR and MR in glia have been implicated in various 
pathologies.  In mice tissue, the BLA-complex has been demonstrated to express GR, 
but not MR in oligodendrocytes, which may have implications for neurological 
pathologies such as multiple sclerosis (Matsusue et al., 2014).  Additionally (as 
stated in Chapter 2), patients with depression have shown increased GR populations 
in astrocytes in the LA, BA and CeA, compared to healthy controls (Q. Wang et al., 
2014).  Our method of immunofluorescence and 3D reconstruction for colocalisation 
could be utilised in future research, to further investigate the role of GR and MR in 
glial cells, which is still poorly understood. 
Distribution Densities of GR and MR 
Distribution of gGR and gMR in Amygdala Subnuclei 
The distribution of receptors have been shown to follow the same pattern in 
corticosteroid binding (Reul et al., 1987), and understanding the distribution density 
within the amygdala could further our understanding of the stress response.  As such, 
volumetric quantification was performed using Fogarty’s approach, which allowed 
us to compare the relative distribution densities between GR and MR.  Genomic GR 
and MR are responsible for the slow effects of stress (Prager & Johnson, 2009), and 
are expressed in high density in the amygdala (Reul & de Kloet, 1985).  In our study, 
we found that genomic GR was found to have the highest density within the CeA 
with minimal differences in density between the LA and BA.  This was consistent 
with previous light microscopy studies (Ahima & Harlan, 1990; Ahima et al., 1991) 
where the highest density of GR-immunoreactivity was within CeA neurons, while 
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LA and BA neurons had similar levels of immunoreactivity.  With respect to 
genomic MR spots, the CeA showed the highest density, followed by the BA and 
then the LA.  This was somewhat consistent with previous research where Ahima et 
al. (1991) found that the CeA had the highest amount of MR immunoreactive 
neurons, followed by a moderate density in the LA, and the lowest density in the BA.  
It should be noted that the distribution density of MR has shown mixed results, 
although the CeA is consistently shown to have the highest density (Morimoto et al., 
1996), which is consistent with our findings.  Additionally, mosaic images increased 
the confidence that the images used in analysis were sampled from the correct 
subnuclei.  However, due to low power of the current feasibility study, 
generalisability of the results is limited.  On the other hand, preliminary analysis 
appears to be mostly consistent with previous research, which further supports the 
feasibility of using 3D reconstruction in Imaris for quantification. 
We found that genomic receptors had a much higher density compared with 
the receptors colocalised with PSD-95; with nearly ten times as many spots per cubic 
micron.  The high density of genomic receptors was also consistent with previous 
research.  Light microscopy studies have shown that GR and MR immunoreactivity 
was strongest in the nuclei of neurons, with weak labelling in the cytoplasm (Ahima 
& Harlan, 1990; Ahima et al., 1991).  Confocal imaging has shown similar results, 
where the strongest labelling was observed within the nucleus, and weak labelling 
was seen within the cytoplasm of neurons (Han et al., 2014; van Steensel et al., 
1996).  Thus, the density of reconstructed spots was also consistent with the labelling 
seen in previous research, providing further support for the feasibility of the 
approach. 
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Distribution of Genomic and Colocalised Corticosteroid Receptors 
Preliminary analyses did not show a statistically significant difference 
between genomic GR and MR within the amygdala.  This was consistent with 
previous research that tested the receptor balance hypothesis.  For example, Caudal 
et al. (2014) investigated the ratio of GR:MR in the amygdala and found that the 
nuclear levels of GR and MR were quite similar in rat brain homogenates.  This was 
further corroborated by Han et al. (2014),who showed that the neurons in the 
amygdala of stress-naïve rats displayed a similar level of expression of GR and MR.  
Our preliminary analyses did suggest, however, that there could be a statistically 
significant difference between the densities of GR and MR located at the PSD.  In 
the amygdala, we found a higher density of GR spots located at excitatory post-
synaptic terminals compared to MR.  Studies testing the receptor balance hypothesis 
have suggested that the amygdala is not sensitive to changes in the GR:MR ratio 
(Caudal et al., 2014; Han et al., 2014; Harris et al., 2013).  These studies, however, 
either did not demarcate between genomic or membrane-associated receptors, or 
alternatively focused on the GR:MR ratio between genomic receptors (de Kloet, 
2014).  The high density of genomic receptors could potentially mask the effects of 
membrane-associated populations, which have a central role in our acute response to 
stress (Quaedflieg et al., 2015; Vogel et al., 2014).  Moreover, mGR and mMR have 
less transient effects in the amygdala compared to mGR and mMR in the 
hippocampus (Sarabdjitsingh & Joels, 2014; Sarabdjitsingh et al., 2012), which is an 
area that is sensitive to the receptor balance hypothesis (de Kloet et al., 2008).  This, 
in conjunction with our findings, could provide a new direction for research 
investigating the receptor balance hypothesis in the amygdala.  The ratio between 
 Chapter 6: Discussion 119 
mGR:mMR could add a new dimension to the receptor balance hypothesis and 
further our understanding of the stress system. 
Proportion of Excitatory Post-synaptic Terminals Containing Corticosteroid 
Receptors 
In the amygdala, excitatory inter- and intra-cellular pathways are activated 
during stress (Z. Liu et al., 2014; Maras, 2014).  As a result, we were interested in 
examining the proportion of excitatory post-synaptic terminals containing 
corticosteroid receptors in the amygdala.  Moreover, previous electron microscopy 
studies have shown that while some excitatory synapses contain mGR and mMR, the 
overall distribution is unclear (L. R. Johnson et al., 2005; Prager et al., 2010).  In this 
study, we used Fogarty’s approach to perform some preliminary analyses on the 
amount of excitatory post-synaptic terminal that contained GR or MR.  In the 
amygdala, we found that the proportion of excitatory post-synaptic terminals 
containing GR was around 9.28%, nearly twice as high the amount of excitatory 
post-synaptic terminals containing MR (~5.27%).  This was interesting as activation 
of mMR in the amygdala has been shown to increase neuronal excitability at post-
synaptic sites, whereas mGR has been shown to attenuate neuronal excitability 
(Karst et al., 2010; Sarabdjitsingh et al., 2012).  Additionally, mGR appears to have a 
larger functional role upon repeated exposures to stress (Karst et al., 2010), as 
opposed to the animals used in this study, which were stress-naïve.  As yet, it is 
unknown how the densities of mGR and mMR at synapses translate to functional 
differences; however, the method detailed in this thesis could be applied to future 
studies to better understand this. 
Despite being part of the amygdala, the LA, CeA and BA differ both 
structurally and functionally (Sah et al., 2003; Sah & Lopez de Armentia, 2003).  As 
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such, we were also interested to see whether the proportion of GR and MR at 
excitatory post-synaptic sites differed within the different amygdala subnuclei.  Our 
results, while tentative, suggested that the CeA contained a higher proportion of 
excitatory post-synaptic terminals containing GR compared with the LA and the BA.  
But no statistically significant difference between amygdala subregions was found 
for post-synaptic terminals containing MR.  These results were interesting, as 
previous electrophysiological studies have shown that the application of 
corticosterone affects excitatory post-synaptic currents in the BA, but not the CeA 
(Karst et al., 2010).  However, the CeA, while containing a high density of inhibitory 
interneurons, also receives many excitatory inputs from the LA and BA (Sah et al., 
2003; Sah & Lopez de Armentia, 2003).  In addition, CeA knockout studies have 
shown that GRs have a large role in modulating neuronal excitability compared with 
MR (A. C. Johnson & Meerveld, 2015; Kolber et al., 2008).  Corticosteroids in the 
CeA affect the behavioural output in stressful situations (Kolber et al., 2008; 
Roozendaal, 2000; Simms et al., 2012) and further delineating region-specific 
differences could have further functional implications. 
Due to the small sample size of this study, however, further research is 
needed to corroborate these results.  Nonetheless, we were able to use Fogarty’s 
approach to demonstrate the distribution densities of genomic GR and MR in fixed 
amygdala sections – which was in line with the available literature (Ahima & Harlan, 
1990; Ahima et al., 1991; Morimoto et al., 1996; Reul & de Kloet, 1985; Reul et al., 
1987).  Using 3D reconstruction for object-based colocalisation analysis, we were 
also able to see the distribution densities of GR and MR located at excitatory post-
synaptic sites.  In future studies, PSD-95 markers could be substituted with other 
subcellular labels.  Moreover, this approach can be used to visualise the effects of 
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behavioural or drug interventions.  The wide applicability of this approach can be 
used to provide a better resolution of the functional role of membrane-associated GR 
and MR in the stress response. 
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Chapter 7:  Conclusions 
While there have been previous studies characterising the neuronal 
distribution of corticosteroid receptors, this was the first study to test feasibility of 
using 3D immunofluorescent reconstruction to characterise and quantify GR and MR 
at synaptic sites.  In this thesis I aimed to test the feasibility of adapting Fogarty’s 
approach to visualising mGR and mMR at excitatory post-synaptic terminals in fixed 
amygdala sections.  As stated in Chapter 1, the thesis objectives were as follows: 
1. Validate the antibodies and reagents from the electron-microscope studies 
conducted by L. R. Johnson et al. (2005) and Prager et al. (2010), for use in 
multiple labelling immunofluorescence. 
2. Adapt Fogarty’s approach to investigate the distribution of GR and MR in 
nuclei and at excitatory post-synaptic terminals. 
3. Quantify the balance between these receptors in stress-naïve animals in order 
to provide a foundation for future studies into stress. 
Reagent and Protocol Validation 
In Chapter 4, we established a standardised protocol for confocal imaging.  
We used primary antibodies that had demonstrated sensitivity and specificity to their 
respective proteins (detailed in Chapter 3), and optimised their concentrations for 
fluorescent imaging.  We also established the specificity of the fluorescent labels for 
each primary antibody and developed a protocol which was used in for 3D 
reconstruction and colocalisation analysis in Chapter 5.  We also found that PSD-95- 
and GR-like labelling met the criterion for 3D spot reconstruction.  MR-like puncta 
were not as well defined; however, we corrected for in Chapter 5.  Using triple-
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labelling immunofluorescence, we found that GR and MR were located within the 
DAPI-stained nuclei, and also appeared to be colocalised with PSD-95 which was 
consistent with previous electron microscopy studies (L. R. Johnson et al., 2005; 
Prager et al., 2010).  In our design we varied GR- and MR-labelling between 
sections, but as GR and MR are largely colocalised within neurons (Han et al., 2014; 
van Steensel et al., 1996), characterising the distribution of GR and MR puncta 
within the same sample could be another application for this technique; although 
different primary antibodies would need to be used.  As antibody labelling can vary 
(Sarabdjitsingh et al., 2010), future studies using different reagents should be 
optimised accordingly, to ensure that labelling meets the criteria for 3D spot 
reconstruction (Fogarty et al., 2013). 
3D reconstruction of Corticosteroid Receptors 
In Chapter 5, we applied the protocol established in Chapter 4, to further 
characterise the distribution of GR and MR labelling in the amygdala.  We observed 
puncta labelling of receptors and PSD-95 in the raw image, although the quality of 
the puncta labelling improved after deconvolution.  The distinctiveness of the puncta 
labelling subsequent to deconvolution techniques was in line with previous research; 
improving the reliability of colocalisation analysis (Dodt et al., 2007; Zinchuk & 
Grossenbacher-Zinchuk, 2009).  As such, it is strongly recommended that 
deconvolution techniques are used in future studies employing this technique. 
From the fluorescent labels that were imaged, DAPI-labelling was three-
dimensionally recreated as neuronal surfaces, and puncta-labelling was recreated as 
spots.  We found that re-creation of DAPI-surfaces allowed us to view and quantify 
the spatial distribution of genomic GR and MR.  The presentation of labelling, 
coupled with preliminary analysis, suggested that the distribution density of genomic 
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spots was in accordance with previous literature (Ahima & Harlan, 1990; Ahima et 
al., 1991; van Steensel et al., 1996). 
We also found that GR and MR spots were colocalised with PSD-95 spots.  
Subsequent to 3D reconstruction we were able to perform object-based colocalisation 
analysis.  This allowed us to perform preliminary analyses on the subpopulations of 
GR and MR located at excitatory post-synaptic sites.  Our findings indicated that 
there could potential be a higher amount of GR colocalised with PSD-95 compared 
to MR.  As synaptic GR and MR in the amygdala have been implicated in the 
maintenance of maladaptive cognitions and behaviours (Karst et al., 2010), it is 
possible that the amygdala may be sensitive to differences between ratios of mGR 
and mMR, and the high density of genomic receptors mask this effect.  However, due 
to the limited power of this study, these findings are still tentative.  Future studies 
employing 3D reconstruction for object-based colocalisation are needed to confirm 
this. 
Finally, we found that the approach developed here was feasible for 
investigating the distribution densities of GR and MR.  We conclude, based on our 
initial quantifications, that this approach can be used in future studies to directly test 
for differences within the different amygdala subnuclei.  Our results suggested that 
there could be a higher amount of GR at excitatory post-synaptic sites in the CeA.  
As the CeA is responsible for behavioural responses to stressful stimuli (Kolber et 
al., 2008; Roozendaal, 2000; Simms et al., 2012), further delineating these 
differences could have implications for various stress related pathologies (Hermans 
et al., 2014). 
Stress can cause acute changes to cognition and behaviour (Groeneweg et al., 
2012), and chronic stress can even lead to the development of various pathologies 
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(Millan et al., 2012).  At a cellular level, a balance between the populations of GR 
and MR appear important for maintaining homeostasis (de Kloet, 1991), and a 
disruption to these corticosteroid receptors have been implicated in a variety of 
maladaptive behaviours (Harris et al., 2013).  Further understanding the role of GR 
and MR at the synapse, may help us better understand stress.  In this thesis, we tested 
a relatively novel method for characterising these receptors; with the hopes of 
providing a robust technique that can be adapted to various forms of stress research 
to better understand the role of these receptors in stress. 
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Acquisition Parameters of Images with Olympus FV1200 
 Solid State Laser 
 LD 405nm (50nw) LD 473nm (15mw) LD 559nm (15mw) 
Laser Power 0.9% 3.0% (GR)/5.0% (MR) 3.0% 
HV 855 760 (GR)/810 (MR) 800 
Offset 1 1 1 
Gain 37 46 (GR)/40 (MR) 37 
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Appendix C 
Nyquist Sampling Parameters 
Table 3 
Nyquist Sampling Parameters from Scientific Volume Imaging (n.d.) 
Microscopy Parameter Value 
Microscope Type Confocal 
Numerical Aperture 1.35 
Excitation Wavelength 488 
Emission Wavelength 520 
Number of Excited Photons 1.0 




Scientific Volume Imaging. (n.d.). Microscopy Nyquist rate and PSF calculator. 
Retrieved from: https://svi.nl/NyquistCalculator 
  










Links to Supplementary Videos of 3D Objects in Imaris (Bitplane) 
Video URL 
Video 1, Process of 3D Reconstruction https://youtu.be/9kgq69dt1ls 
Video 2, High Magnification view of 3D objects in Imaris https://youtu.be/cs3e4UxgAdY 
 
